TW201601692A - Absorbent article - Google Patents

Absorbent article Download PDF

Info

Publication number
TW201601692A
TW201601692A TW104118147A TW104118147A TW201601692A TW 201601692 A TW201601692 A TW 201601692A TW 104118147 A TW104118147 A TW 104118147A TW 104118147 A TW104118147 A TW 104118147A TW 201601692 A TW201601692 A TW 201601692A
Authority
TW
Taiwan
Prior art keywords
emulsion
absorbent article
acid
mass
colloidal
Prior art date
Application number
TW104118147A
Other languages
Chinese (zh)
Other versions
TWI654968B (en
Inventor
Ichiro Wada
Masashi Nakashita
Original Assignee
Uni Charm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Charm Corp filed Critical Uni Charm Corp
Publication of TW201601692A publication Critical patent/TW201601692A/en
Application granted granted Critical
Publication of TWI654968B publication Critical patent/TWI654968B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/47Sanitary towels, incontinence pads or napkins
    • A61F13/472Sanitary towels, incontinence pads or napkins specially adapted for female use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/49Absorbent articles specially adapted to be worn around the waist, e.g. diapers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Cosmetics (AREA)

Abstract

The purpose of the present disclosure is to provide an absorbent article that can continuously discharge onto the skin of a wearer a lotion that protects the skin of the wearer. An absorbent article according to the present disclosure has the following structure. An absorbent article (1) that comprises a liquid-permeable layer (2), a liquid-impermeable layer, and an absorption layer (3) that is between the liquid permeable layer (2) and the liquid-impermeable layer. The absorbent article (1) is characterized in that, in at least one portion of a region that contacts the skin of a wearer, the absorbent article (1) has a gel lotion (6) that includes a gelling agent and a lotion, the gelling agent including a styrene elastomer, the lotion including a hydrocarbon, and the gel lotion (6) having a compressive stress at 50% strain of 1-100 kPa.

Description

吸收性物品 Absorbent article

本發明關於一種吸收性物品。 The present invention relates to an absorbent article.

吸收性物品,例如生理用衛生棉、護墊等,經由長年累積的技術開發,已漸漸地提升基本性能,與以往相比,吸收經血等***物之後,外漏等較少發生,目前更進一步追求高機能化,例如具有貼近肌膚的著用感。 Absorbent articles, such as sanitary napkins and pads, have been gradually developed to improve basic performance through years of accumulated technology. Compared with the past, absorption of excretions such as menstrual blood, leakage, etc. occur less frequently. The pursuit of high performance, for example, has a sense of closeness to the skin.

且,例如引證1中記載一種吸收性物品,其係在頂部薄片之外表面中的至少一部分包含有效量的乳液塗覆,該乳液塗覆在20℃下為半固體或固體,且能夠部分地移動到著用者的肌膚。且,上述乳液塗覆中包含:10~95%之(i)在20℃下具有可塑性或流動一致性,並包含選自石油基底之柔軟劑、脂肪酸酯柔軟劑、烷基乙氧基化柔軟劑、以及此等之混合物中的1種,且實質上不包含水分之柔軟劑、與5~90%之(ii)能夠將柔軟劑固定在頂部薄片的外表面上之固定化物質,且前述固定化物質具有至少35℃,較佳為至少40℃之融點,並選自多元羥基脂肪酸酯、多元羥基脂肪酸醯胺、C14-C22脂肪醇、C12-C22脂肪 酸、C12-C22脂肪醇乙氧基化物、以及此等之混合物。 Also, for example, reference is made to an absorbent article comprising at least a portion of the outer surface of the top sheet comprising an effective amount of an emulsion coating which is semi-solid or solid at 20 ° C and capable of being partially Move to the user's skin. Moreover, the above emulsion coating comprises: 10 to 95% (i) having plasticity or flow consistency at 20 ° C, and comprising a softener selected from a petroleum base, a fatty acid ester softener, an alkyl ethoxylation a softening agent, and one of such a mixture, and a softening agent that does not substantially contain moisture, and 5 to 90% of (ii) an immobilizing substance capable of fixing the softening agent to the outer surface of the top sheet, and The immobilized substance has a melting point of at least 35 ° C, preferably at least 40 ° C, and is selected from the group consisting of polyhydroxyalkanoates, polyhydroxy fatty acid decylamines, C 14- C 22 fatty alcohols, C 12- C 22 fatty acids, C 12- C 22 fatty alcohol ethoxylate, and mixtures thereof.

[先行技術文獻] [Advanced technical literature] [引用文獻] [Citation]

[引證1]日本特表平10-509896號公報 [Citation 1] Japanese Special Report No. 10-509896

引證1中,具有35℃以上之融點的固定化物質由於在乳液塗覆中於室溫(25℃)下會結晶化,乳液塗覆的黏度會升高,具有使乳液塗覆不動化之作用。 In Citation 1, an immobilized material having a melting point of 35 ° C or higher is crystallized at room temperature (25 ° C) in emulsion coating, and the viscosity of the emulsion coating is increased, and the emulsion coating is immobilized. effect.

然而,使用固定化物質使乳液塗覆不動化(高黏度化)的話,本身就存在著有效成分之「柔軟劑」會難以從乳液塗覆中釋出的問題點。且,即使將乳液塗覆不動化(高黏度化),在體壓等高壓力之下,乳液塗覆會移動至吸收性物品的內部(頂部薄片之纖維的空隙等),會有「柔軟劑」難以持續對著用者的肌膚產生作用之問題點。 However, when the immobilized material is used to imprint the emulsion (high viscosity), there is a problem that the "softener" of the active ingredient is difficult to release from the emulsion coating. Moreover, even if the emulsion is coated immovable (high viscosity), under the high pressure such as body pressure, the emulsion coating moves to the inside of the absorbent article (the void of the fibers of the top sheet, etc.), and there is a "softener". It is difficult to continue to have problems with the user's skin.

因此,本發明之目的為提供一種將保護著用者肌膚的乳液連續地釋放至著用者肌膚之吸收性物品。 Accordingly, an object of the present invention is to provide an absorbent article which continuously releases an emulsion for protecting a user's skin to the skin of a user.

本發明者們發現一種吸收性物品,其特徵為具備液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層之吸收性物品,且 上述吸收性物品在與著用者肌膚接觸的區域中至少一部分具有包含膠體化劑與乳液之膠體乳液,上述膠體化劑包含苯乙烯系彈性體,上述乳液包含烴,且上述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 The present inventors have found an absorbent article comprising an absorbent article comprising a liquid permeable layer, a liquid impermeable layer, and an absorbent layer between the liquid permeable layer and the liquid impermeable layer, and The absorbent article has a colloidal emulsion containing a colloidizing agent and an emulsion in at least a portion of the area in contact with the skin of the user, the colloidizing agent comprising a styrene-based elastomer, the emulsion comprising a hydrocarbon, and the colloidal emulsion having 1~ Compressive stress at 50% deformation of 100 kPa.

本發明之吸收性物品能夠連續地釋放出保護著用者肌膚之乳液至著用者肌膚。 The absorbent article of the present invention can continuously release the emulsion which protects the user's skin to the user's skin.

1‧‧‧吸收性物品 1‧‧‧Absorbables

2‧‧‧頂部薄片 2‧‧‧Top sheet

3‧‧‧吸收體 3‧‧‧ absorber

4‧‧‧側邊薄片 4‧‧‧Side sheet

5‧‧‧壓印部 5‧‧‧ Imprinting Department

6‧‧‧膠體乳液 6‧‧‧colloidal emulsion

[圖1]圖1表示根據本發明實施形態的1個吸收性物品1之平面圖。 Fig. 1 is a plan view showing an absorbent article 1 according to an embodiment of the present invention.

[圖2]圖2表示根據有別於本發明實施形態之吸收性物品1的平面圖。 Fig. 2 is a plan view showing an absorbent article 1 according to an embodiment of the present invention.

針對本發明之吸收性物品,以下進行詳細的說明。 The absorbent article of the present invention will be described in detail below.

本發明之吸收性物品具備液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層。 The absorbent article of the present invention comprises a liquid permeable layer, an opaque layer, and an absorbing layer between the liquid permeable layer and the liquid permeable layer.

本發明之吸收性物品,在與著用者肌膚接觸的區域之至少一部分中,亦即在肌膚接觸區域中具有膠體乳液,該 膠體乳液包含膠體化劑與乳液。 The absorbent article of the present invention has a colloidal emulsion in at least a part of a region in contact with the skin of the user, that is, in a skin contact region, The colloidal emulsion contains a colloidizing agent and an emulsion.

[膠體乳液] [colloidal emulsion]

本發明之吸收性物品中,膠體乳液包含膠體化劑與乳液。 In the absorbent article of the present invention, the colloidal emulsion contains a colloidizing agent and an emulsion.

膠體化劑係為了保持上述乳液之成分,包含苯乙烯系彈性體。 The colloidalizing agent contains a styrene-based elastomer in order to retain the components of the above emulsion.

作為上述苯乙烯系彈性體,具有硬段以及軟段者較佳,且作為上述硬段,以聚苯乙烯嵌段較佳,且作為上述軟段,以聚烯烴嵌段較佳。 The styrene-based elastomer preferably has a hard segment and a soft segment, and is preferably a polystyrene block as the hard segment, and a polyolefin block as the soft segment.

上述聚苯乙烯嵌段中不僅包含苯乙烯之同元共聚物而成的嵌段(亦即聚苯乙烯嵌段),亦包含α-甲基苯乙烯之同元共聚物而成的嵌段(亦即聚α-甲基苯乙烯嵌段)、以及苯乙烯與α-甲基苯乙烯之共聚合物而成的嵌段。 The above polystyrene block includes not only a block of a homopolymer of styrene (that is, a polystyrene block) but also a block of a homopolymer of α-methylstyrene ( That is, a block of a poly-α-methylstyrene block and a copolymer of styrene and α-methylstyrene.

作為上述聚烯烴嵌段,有舉例如聚烯烴之同元共聚物而成之嵌段,例如聚乙烯嵌段、聚丙烯嵌段、聚丁烯嵌段、以及聚丁二烯嵌段、以及聚烯烴之共聚合物而成之嵌段、例如乙烯、丙烯、丁烯以及丁二烯等之共聚合物而成之嵌段。 As the above polyolefin block, there may be mentioned, for example, a block of a homopolymer of polyolefin, such as a polyethylene block, a polypropylene block, a polybutene block, and a polybutadiene block, and a poly A block formed of a copolymer of an olefin, for example, a copolymer of ethylene, propylene, butylene, and butadiene.

且,本說明書中,在方便上,丁二烯也作為正烯系單體使用。 Further, in the present specification, butadiene is also used as a normal olefin monomer.

且,上述軟段中亦包含聚丁二烯嵌段之氫加成物、以及丁二烯與乙烯、丙烯、丁烯及丁二烯等之共聚合物而成的嵌段之氫加成物。 Further, the soft segment further comprises a hydrogen adduct of a polybutadiene block and a hydrogen adduct of a block of butadiene and a copolymer of ethylene, propylene, butylene and butadiene. .

作為上述苯乙烯系彈性體,以在兩末端具有硬段,並在此等之間具有1種或複數種軟段較佳。 The styrene-based elastomer preferably has a hard segment at both ends, and one or a plurality of soft segments are preferably provided between the two.

作為上述苯乙烯系彈性體之具體例,有舉例如以下。 Specific examples of the styrene-based elastomer are as follows.

(i)聚苯乙烯-block-聚(乙烯-co-丙烯) (i) polystyrene-block-poly(ethylene-co-propylene)

(以下,有時省略成「SEP」) (The following may be omitted as "SEP")

(ii)聚苯乙烯-block-聚(乙烯-co-丙烯)-block-聚苯乙烯 (ii) polystyrene-block-poly(ethylene-co-propylene)-block-polystyrene

(以下,有時省略成「SEPS」) (The following may be omitted as "SEPS")

(iii)聚苯乙烯-block-聚(乙烯-co-丁烯)-block-聚苯乙烯 (iii) polystyrene-block-poly(ethylene-co-butylene)-block-polystyrene

(以下,有時省略成「SEBS」) (The following may be omitted as "SEBS")

(iv)聚苯乙烯-block-聚乙烯-block-聚(乙烯-co-丙烯)-block-聚苯乙烯 (iv) polystyrene-block-polyethylene-block-poly(ethylene-co-propylene)-block-polystyrene

(以下,有時省略成「SEEPS」) (The following may be omitted as "SEEPS")

上述苯乙烯系彈性體較佳為具有5,000~500,000,再較佳為具有10,000~400,000,且更較佳為具有50,000~300,000之重量平均分子量。若上述重量平均分子量低於5,000,則苯乙烯系彈性體會有難以保持在膠體構造之傾向,且若上述重量平均分子量超過500,000,則所形成之膠體的50%變形時的壓縮應力會變高,著用感會有降低之傾向。 The styrene-based elastomer preferably has a weight average molecular weight of 5,000 to 500,000, more preferably 10,000 to 400,000, and still more preferably 50,000 to 300,000. When the weight average molecular weight is less than 5,000, the styrene-based elastomer tends to be difficult to maintain in the colloidal structure, and if the weight average molecular weight exceeds 500,000, the compressive stress at 50% deformation of the formed colloid becomes high. There is a tendency to reduce the sense of use.

且,重量平均分子量之測定方法如後述。 Further, the method for measuring the weight average molecular weight will be described later.

上述苯乙烯系彈性體較佳為包含10~50質量%之聚苯乙烯嵌段與50~90質量%之聚烯烴嵌段,再較佳為包含15~40質量%之聚苯乙烯嵌段與60~85質量%之聚烯 烴嵌段,且更較佳為包含18~35質量%之聚苯乙烯嵌段與65~82質量%之聚烯烴嵌段。 The styrene-based elastomer preferably contains 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block, and more preferably 15 to 40% by mass of a polystyrene block. 60 to 85% by mass of polyolefin The hydrocarbon block, and more preferably contains 18 to 35% by mass of a polystyrene block and 65 to 82% by mass of a polyolefin block.

若聚苯乙烯嵌段的量低於10質量%,則會有聚苯乙烯嵌段難以形成後述微米層分離構造之傾向。若聚苯乙烯嵌段的量超過50質量%,則能夠保持乳液之聚烯烴嵌段的量變少,故能夠保持之乳液的量會有變少之傾向。且,聚苯乙烯嵌段之微米層分離構造的量變多,所形成的膠體乳液會凝固,會有著用感變差之傾向。 When the amount of the polystyrene block is less than 10% by mass, the polystyrene block tends to be difficult to form a micron-separated structure described later. When the amount of the polystyrene block exceeds 50% by mass, the amount of the polyolefin block capable of holding the emulsion is reduced, so that the amount of the emulsion that can be held tends to be small. Further, the amount of the micron layer separation structure of the polystyrene block is increased, and the formed colloidal emulsion is solidified, which tends to deteriorate the feeling of use.

上述苯乙烯系彈性體會生成膠體乳液之理由如以下所述。苯乙烯系彈性體之硬段會互相凝集形成一範圍,並有作為交聯點之作用。另一方面,軟段會發揮連結此等交聯點之網孔的角色。其結果,苯乙烯系彈性體具有作為彈性體之機能。 The reason why the above styrene-based elastomer forms a colloidal emulsion is as follows. The hard segments of the styrene elastomer will agglomerate to each other to form a range and function as a crosslinking point. On the other hand, the soft segment will play the role of the mesh connecting these cross-linking points. As a result, the styrene-based elastomer has a function as an elastomer.

將上述苯乙烯系彈性體與上述乳液,尤其是與烴基混合後,苯乙烯系彈性體之軟段會保持上述乳液,另一方面,硬段會維持在形成一範圍之狀態。其結果,苯乙烯系彈性體與上述乳液之混合物(膠體乳液)具有下述彈性體之機能,該彈性體具有比苯乙烯系彈性體單體更低的壓縮應力。 When the styrene-based elastomer is mixed with the above emulsion, particularly with a hydrocarbon group, the soft segment of the styrene-based elastomer retains the emulsion, and on the other hand, the hard segment is maintained in a state of being formed. As a result, the mixture of the styrene-based elastomer and the above emulsion (colloidal emulsion) has the function of an elastomer having a lower compressive stress than the styrene-based elastomer monomer.

且,上述乳液僅會被保持在苯乙烯系彈性體之軟段中較鬆的網孔,並能夠移動到膠體乳液的表面。 Moreover, the above emulsion is only retained in the looser mesh in the soft section of the styrenic elastomer and can be moved to the surface of the colloidal emulsion.

上述乳液包含烴。本說明書中,「烴」意指碳與氫而成之化合物。作為上述烴,有舉出鏈狀烴,例如石臘系烴(不包含雙鍵以及三鍵,亦稱作烷)、正烯系烴(包 含1個雙鍵,亦稱作烯)、乙炔系烴(包含1個三鍵,亦稱作炔)、及包含2個以上選自雙鍵以及三鍵所成群中之鍵結的烴、以及環狀烴,例如芳香族烴、脂環式烴。 The above emulsion contains a hydrocarbon. In the present specification, "hydrocarbon" means a compound in which carbon and hydrogen are formed. Examples of the hydrocarbon include a chain hydrocarbon such as a paraffinic hydrocarbon (excluding a double bond and a triple bond, also referred to as an alkane), and a normal olefinic hydrocarbon (package). a double bond, also known as an alkene, an acetylene hydrocarbon (containing one triple bond, also referred to as an alkyne), and a hydrocarbon containing two or more bonds selected from the group consisting of a double bond and a triple bond, And cyclic hydrocarbons such as aromatic hydrocarbons and alicyclic hydrocarbons.

作為上述烴,為鏈狀烴以及脂環式烴較佳,為鏈狀烴再較佳,為石臘系烴、正烯系烴、及包含2個以上之雙鍵的烴(不包含三鍵)更較佳,且為石臘系烴更較佳。 The hydrocarbon is preferably a chain hydrocarbon or an alicyclic hydrocarbon, and more preferably a chain hydrocarbon, and is a paraffinic hydrocarbon, a normal olefinic hydrocarbon, and a hydrocarbon containing two or more double bonds (excluding a triple bond) More preferably, it is more preferred as a paraffinic hydrocarbon.

上述鏈狀烴中包含直鏈狀烴以及分支狀烴。 The chain hydrocarbons include linear hydrocarbons and branched hydrocarbons.

上述烴為在40℃中具有0.01~80mm2/s之動力黏度較佳,具有0.01~4.0質量%之抱水率較佳,且具有未滿1,000之重量平均分子量較佳。是因為烴可作為後述之體液滑性賦予劑來作用。 The above hydrocarbon has a dynamic viscosity of preferably 0.01 to 80 mm 2 /s at 40 ° C, a water absorbing ratio of 0.01 to 4.0% by mass, and a weight average molecular weight of less than 1,000. This is because hydrocarbons can act as a body fluid slip imparting agent to be described later.

本發明之膠體乳液中,乳液(例如烴)會有一定量滲出到膠體乳液的表面。滲出到表面的乳液會移動到著用者的肌膚,或者會與經血、尿等體液一起滑落到吸收體內部等而消失,之後新的乳液會從膠體乳液再滲出。因此,膠體乳液能夠連續地釋放出乳液。 In the colloidal emulsion of the present invention, an emulsion (e.g., a hydrocarbon) will have a certain amount of exudation to the surface of the colloidal emulsion. The emulsion that has oozing out to the surface will move to the user's skin, or will disappear with the body fluid such as menstrual blood or urine, and disappear into the inside of the absorbent body, and then the new emulsion will re-bleed out from the colloidal emulsion. Therefore, the colloidal emulsion is capable of continuously releasing the emulsion.

上述乳液較佳為包含50~100質量%,再較佳為包含60~100質量%,且更較佳為包含70~100質量%之上述烴。這是以膠體形成之觀點來看。 The above emulsion preferably contains 50 to 100% by mass, more preferably 60 to 100% by mass, and still more preferably 70 to 100% by mass of the above hydrocarbon. This is in terms of colloid formation.

上述膠體乳液中,作為上述乳液,除了上述烴以外,亦能夠進一步包含該發明所屬技術領域中熟知用來作為乳液之成分。 In the above colloidal emulsion, as the above-mentioned emulsion, in addition to the above hydrocarbons, it is possible to further comprise a component which is well known as an emulsion in the technical field of the invention.

上述膠體乳液中,作為上述乳液,除了上述烴以外, 進一步包含體液滑性賦予劑較佳,該體液滑性賦予劑具有超過0.00且0.60以下之IOB、與40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 In the above-mentioned colloidal emulsion, it is preferable to further include a body fluid slip imparting agent as the above-mentioned emulsion, and the body fluid slip imparting agent has an IOB of more than 0.00 and 0.60 or less, and 0.01 to 80 mm 2 /s at 40 ° C. The dynamic viscosity, the water holding ratio of 0.01 to 4.0% by mass, and the weight average molecular weight of less than 1,000.

上述體液滑性賦予劑為本案申請人之申請案,與國際公開第2012/133724號說明書所記載之「血液改質劑」相同成分,且同樣地與國際公開第2013/129236號說明書所記載之「血液滑性賦予劑」為相同成分。 The above-mentioned body fluid slip imparting agent is the same as the "blood modifier" described in the specification of International Publication No. 2012/133724, and is similarly described in the specification of International Publication No. 2013/129236. The "slipperiness imparting agent" is the same component.

藉由上述膠體乳液中包含上述體液滑性賦予劑,體液滑性賦予劑會從膠體乳液連續地釋放出,經過長時間,能夠使到達液體透過性層之體液等迅速地滑落到吸收體的內部。 When the body fluid slip imparting agent is contained in the colloidal emulsion, the body fluid slip imparting agent is continuously released from the colloidal emulsion, and the body fluid or the like reaching the liquid permeable layer can be quickly slipped to the inside of the absorbent body over a long period of time. .

IOB(Inorganic Organic Balance)為表示親水性以及親油性之平衡的指標,本說明書中是意指根據小田等之下式:IOB=無機性值/有機性值所算出之值。 IOB (Inorganic Organic Balance) is an index indicating the balance between hydrophilicity and lipophilicity, and in the present specification, it means a value calculated according to the formula of Oda et al.: IOB=inorganic value/organicity value.

上述無機性值與有機性值意指基於藤田穆「有機化合物之預測與有機概念圖」化學區域Vol.11,No.10(1957)p.719-725)所記載之有機概念圖。 The above inorganic value and organic value mean an organic concept map described in Fujita Mu's "Organic Compound Prediction and Organic Concept Map" Chemical Region Vol. 11, No. 10 (1957) p. 719-725).

藤田氏之主要的基之有機性值以及無機性值統整於下述表1。 The main organic and inorganic values of Fujita's base are summarized in Table 1 below.

上述動力黏度是根據JIS K 2283:2000之「5.動力黏度試驗方法」,並使用Cannon-Fenske逆流形黏度計,在40℃之試驗溫度下測定。 The above dynamic viscosity is measured according to "5. Dynamic viscosity test method" of JIS K 2283:2000, and measured at a test temperature of 40 ° C using a Cannon-Fenske counter-flow viscosity meter.

本說明書中,上述「抱水率」意指物質所保持之水的比率,並由以下來進行測定。 In the present specification, the above-mentioned "water holding ratio" means the ratio of the water retained by the substance, and is measured by the following.

(1)在40℃之恆溫室中將試驗管、橡皮塞、應測定之物質以及去離子水靜置24小時。 (1) The test tube, the rubber stopper, the substance to be measured, and deionized water were allowed to stand in a thermostatic chamber at 40 ° C for 24 hours.

(2)在上述恆溫室中,於20mL的試驗管內放入應測定之物質5.0g與去離子水5.0g。 (2) In the above-mentioned constant temperature chamber, 5.0 g of the substance to be measured and 5.0 g of deionized water were placed in a test tube of 20 mL.

(3)在上述恆溫室中,以橡皮拴拴住試驗管口,迴轉1次,靜置5分鐘。 (3) In the above-mentioned constant temperature chamber, the test tube was clamped with a rubber, rotated once, and allowed to stand for 5 minutes.

(4)在上述恆溫室中,將3.0g應測定之物質的層(通常為上層),採取至直徑90mm之質量:W0(g)的玻璃製器皿上。 (4) In the above-mentioned constant temperature chamber, 3.0 g of the substance to be measured (usually the upper layer) was taken up to a glass vessel having a diameter of 90 mm and a mass of W 0 (g).

(5)將上述器皿於烤箱內以105℃加熱3小時,使水分 蒸發,並連同器皿測定質量:W1(g)。 (5) The above vessel was heated in an oven at 105 ° C for 3 hours to evaporate water, and the mass was measured together with the vessel: W 1 (g).

(6)將抱水率根據以下之式算出。 (6) The water holding ratio is calculated according to the following formula.

抱水率(質量%)=100×[W0(g)-W1(g)]/3.0(g) Water holding capacity (% by mass) = 100 × [W 0 (g) - W 1 (g)] / 3.0 (g)

實施3次測定,並採用平均值。 Three measurements were performed and the average was used.

本說明書中,上述「重量平均分子量」包含多分散系之化合物(例如由先後聚合所製造之化合物、複數之脂肪酸、與複數之脂肪族一元醇類所生成之酯)、與單一化合物(例如1種脂肪酸、與1種脂肪族一元醇類所生成之酯)的概念,並且意指在Ni個分子量Mi的分子(i=1或i=1,2...)所構成的系統中,由下述式:Mw=ΣNiMi 2/ΣNiMi所求得之MwIn the present specification, the above "weight average molecular weight" includes a polydisperse compound (for example, a compound produced by sequential polymerization, a plurality of fatty acids, an ester formed with a plurality of aliphatic monohydric alcohols), and a single compound (for example, 1). fatty acids, with an aliphatic monohydric alcohol species generated by the ester) concept, and the mean molecular number molecular weight M i N i a (i = 1 or a system i = 1,2 ...) composed of , by the following formula: M w = ΣN i M i 2 / ΣN i M i are obtained by the M w.

本說明書中,重量平均分子量意指由透膠層析術(GPC)所求之聚苯乙烯換算的值。 In the present specification, the weight average molecular weight means a polystyrene-converted value obtained by gel permeation chromatography (GPC).

作為GPC之測定條件,有舉例如以下。 The measurement conditions of GPC are as follows, for example.

機種:(股)日立High-Technologies製 高效能液相層析Lachrom Elite Model: (share) Hitachi High-Technologies system High performance liquid chromatography Lachrom Elite

管柱:昭和電工(股)製SHODEX KF-801、KF-803以及KF-804 Pipe column: SHODEX KF-801, KF-803 and KF-804 made by Showa Denko (share)

溶析液:THF Lysate: THF

流量:1.0mL/分 Flow rate: 1.0mL/min

打入量:100μL Driving amount: 100μL

檢測:RI(示差折射計) Detection: RI (differential refractometer)

上述體液滑性賦予劑較佳為選自下述(i)及 (ii)、以及此等之任意組合所成之群,(i)具有(i-1)與(i-2)之化合物,(i-1)為烴基部分,(i-2)為被***上述烴基部分的C-C單鍵之間,且選自羰基(-CO-)以及氧基(-O-)所成群中的一個或複數個相同或相異之基、及(ii)具有(ii-1)與(ii-2)與(ii-3)之化合物,(ii-1)為烴基部分,(ii-2)為被***上述烴基部分的C-C單鍵之間,且選自羰基(-CO-)以及氧基(-O-)所成群中的一個或複數個相同或相異之基,(ii-3)為取代上述烴基部分的氫原子,且選自羧基(-COOH)以及氫氧基(-OH)所成群中的一個或複數個相同或相異之基。 The above body fluid slip imparting agent is preferably selected from the following (i) and (ii), and any combination of these, (i) having a compound of (i-1) and (i-2), (i-1) being a hydrocarbon moiety, and (i-2) being inserted Between the CC single bonds of the above hydrocarbon moiety, and one or a plurality of identical or different groups selected from the group consisting of a carbonyl group (-CO-) and an oxy group (-O-), and (ii) having (ii) -1) and (ii-2) and (ii-3), (ii-1) is a hydrocarbyl moiety, (ii-2) is a CC single bond inserted into the above hydrocarbyl moiety, and is selected from a carbonyl group ( -CO-) and one or a plurality of identical or different groups in the group of oxy groups (-O-), (ii-3) being a hydrogen atom replacing the above hydrocarbon group and selected from a carboxyl group (-COOH) And one or a plurality of identical or different groups of the group of hydroxyl groups (-OH).

且,上述烴基部分與上述烴基同義。 Further, the above hydrocarbon group is synonymous with the above hydrocarbon group.

上述(i)以及(ii)之化合物中,有***2個以上的氧基(-O-)時,各氧基(-O-)不相鄰。因此,上述(i)以及(ii)之化合物中不包含氧基連續之化合物(所謂過氧化物)。 In the compounds of the above (i) and (ii), when two or more oxy groups (-O-) are inserted, each oxy group (-O-) is not adjacent. Therefore, the compounds of the above (i) and (ii) do not contain a compound in which an oxy group is continuous (so-called peroxide).

上述體液滑性賦予劑再較佳為選自以下之(i’)及(ii’)、以及此等之任意組合所成之群,(i’)具有(i’-1)與(i’-2)之化合物,(i’-1)為烴基部分,(i’-2)為被***上述烴基部分的C-C單鍵之間,且選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO-)、以及醚鍵(-O-)所成群中的一個或複數個相同或相異之鍵結、及(ii’)具有(ii’-1)與(ii’-2)與(ii’-3)之化合物,(ii’-1)為烴基部分,(ii’-2)為被***上述烴基部分的C-C單鍵之間,且選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO- )、以及醚鍵(-O-)所成群中的一個或複數個相同或相異之鍵,(ii’-3)為取代上述烴基部分之氫原子,且選自羧基(-COOH)以及氫氧基(-OH)所成群中的一個或複數個相同或相異之基。 The body fluid slip imparting agent is preferably further selected from the group consisting of (i') and (ii'), and any combination of the above, (i') having (i'-1) and (i' a compound of -2), (i'-1) is a hydrocarbyl moiety, (i'-2) is a CC single bond inserted into the above hydrocarbyl moiety, and is selected from a carbonyl bond (-CO-), an ester bond (- One or a plurality of identical or different bonds in a group of COO-), carbonate bonds (-OCOO-), and ether bonds (-O-), and (ii') has (ii'-1) And (ii'-2) and (ii'-3), (ii'-1) is a hydrocarbyl moiety, (ii'-2) is a CC single bond inserted into the above hydrocarbyl moiety, and is selected from carbonyl Bond (-CO-), ester bond (-COO-), carbonate bond (-OCOO- And one or a plurality of identical or different bonds in the group of ether bonds (-O-), (ii'-3) is a hydrogen atom substituted for the above hydrocarbon group, and is selected from a carboxyl group (-COOH) and One or a plurality of identical or different groups of hydroxyl groups (-OH).

且,上述烴基部分與上述烴基相同。 Further, the above hydrocarbon group is the same as the above hydrocarbon group.

上述(i’)以及(ii’)之化合物中,***2以上相同或相異之鍵時,亦即***選自羰鍵(-CO-)、酯鍵(-COO-)、碳酸鹽鍵(-OCOO-)以及醚鍵(-O-)中之2個以上相同或相異之鍵時,各個鍵不相鄰,且各個鍵之間至少介隔1個碳原子。 In the above compounds (i') and (ii'), when two or more identical or different bonds are inserted, that is, a bond selected from a carbonyl bond (-CO-), an ester bond (-COO-), or a carbonate bond ( When -OCOO-) and two or more identical or different bonds in the ether bond (-O-), the respective bonds are not adjacent, and at least one carbon atom is interposed between the respective bonds.

作為上述體液滑性賦予劑,有舉出(a1)鏈狀烴四元醇與至少1個脂肪酸之酯、(a2)鏈狀烴三元醇與至少1個脂肪酸之酯、(a3)鏈狀烴二元醇與至少1個脂肪酸之酯、(b1)鏈狀烴四元醇與至少1個脂肪族一元醇類之醚、(b2)鏈狀烴三元醇與至少1個脂肪族一元醇類之醚、(b3)鏈狀烴二元醇與至少1個脂肪族一元醇類之醚、(c1)具有4個羧基的鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯、(c2)具有3個羧基的鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯、(c3)具有2個羧基的鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯、(d1)脂肪族一元醇類與脂肪族一元醇類之醚、(d2)二烷基酮、(d3)脂肪酸與脂肪族一元醇類之酯、(d4)二烷基碳酸酯、(e1)聚氧C3~C6烷二醇、(e2)聚氧C3~C6烷二醇與至少1個脂肪酸之 酯、及(e3)聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚、以及此等之任意組合。 Examples of the body fluid slip imparting agent include (a 1 ) an ester of a chain hydrocarbon tetraol with at least one fatty acid, (a 2 ) a chain hydrocarbon triol and an ester of at least one fatty acid, (a 3 ) a chain hydrocarbon diol with at least one fatty acid ester, (b 1 ) a chain hydrocarbon tetraol and at least one aliphatic monohydric alcohol ether, (b 2 ) a chain hydrocarbon triol and at least 1 An aliphatic monohydric alcohol ether, (b 3 ) a chain hydrocarbon diol and at least one aliphatic monohydric alcohol ether, (c 1 ) a chain hydrocarbon tetracarboxylic acid having four carboxyl groups, a hydroxy acid, An alkoxy acid or an ester of an oxo acid with at least one aliphatic monohydric alcohol, (c 2 ) a chain hydrocarbon tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid and at least one fat An ester of a monohydric alcohol, (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an ester of an oxyacid with at least one aliphatic monohydric alcohol, (d 1 ) fat An ether of a monohydric alcohol and an aliphatic monohydric alcohol, (d 2 )dialkyl ketone, an ester of a (d 3 ) fatty acid and an aliphatic monohydric alcohol, (d 4 ) a dialkyl carbonate, (e 1 ) polyoxy C 3 ~ C 6 alkylene glycol, (e 2) polyoxy C 3 ~ C 6 alkylene glycol and at least one Esters of fatty acids, and (e 3) polyoxy C 3 ~ C 6 alkylene glycol and at least one of the aliphatic monohydric alcohol ethers, and any combination of these.

以下針對此等化合物進行說明。 These compounds are described below.

[(a1)鏈狀烴四元醇與至少1個脂肪酸之酯] [(a 1 ) an ester of a chain hydrocarbon tetraol with at least one fatty acid]

鏈狀烴四元醇意指上述鏈狀烴的氫原子(合計4個)被氫氧基(-OH)(合計4個)所取代之化合物,作為上述鏈狀烴四元醇與至少1個脂肪酸之酯,有舉例如下述式(1): 之季戊四醇與脂肪酸之四酯、下述式(2): 之季戊四醇與脂肪酸之三酯、下述式(3): 之季戊四醇與脂肪酸之二酯、下述式(4): 之季戊四醇與脂肪酸之單酯。(式中、R1~R4分別為鏈狀烴) The chain hydrocarbon tetraol means a compound in which a hydrogen atom (total of 4) of the above chain hydrocarbon is substituted by a hydroxyl group (-OH) (total of 4) as the above chain hydrocarbon tetraol and at least one An ester of a fatty acid, for example, the following formula (1): a tetraester of pentaerythritol and a fatty acid, and the following formula (2): a pentaerythritol and a fatty acid triester, the following formula (3): Diester of pentaerythritol and fatty acid, formula (4): a monoester of pentaerythritol and a fatty acid. (wherein, R 1 to R 4 are each a chain hydrocarbon)

作為構成上述季戊四醇與脂肪酸之酯的脂肪酸(R1COOH、R2COOH、R3COOH以及R4COOH),例如飽和脂肪酸、例如C2~C30之飽和脂肪酸、例如乙酸(C2)(C2表示碳數,且相當於R1C、R2C、R3C或R4C之碳數,以下相同)、丙酸(C3)、丁酸(C4)以及其異構物、例如2-丙酸甲酯(C4)、戊酸(C5)以及其異構物、例如2-丁酸甲酯(C5)、2,2-二丙酸甲酯(C5)、己酸(C6)、庚酸(C7)、辛酸(C8)以及其異構物、例如2-己酸乙酯(C8)、壬酸(C9)、癸酸(C10)、十二酸(C12)、十四酸(C14)、十六酸(C16)、十七酸(C17)、十八酸(C18)、二十酸(C20)、二十二酸(C22)、二 十四酸(C24)、二十六酸(C26)、二十八酸(C28)、三十酸(C30)等、以及沒有被列舉的此等異構物。 As a fatty acid (R 1 COOH, R 2 COOH, R 3 COOH, and R 4 COOH) constituting the above ester of pentaerythritol and a fatty acid, for example, a saturated fatty acid, for example, a C 2 - C 30 saturated fatty acid such as acetic acid (C 2 ) (C) 2 represents a carbon number and corresponds to the carbon number of R 1 C, R 2 C, R 3 C or R 4 C, the same applies hereinafter), propionic acid (C 3 ), butyric acid (C 4 ) and isomers thereof, For example, methyl 2-propionate (C 4 ), valeric acid (C 5 ), and isomers thereof, such as methyl 2-butyrate (C 5 ), methyl 2,2-dipropionate (C 5 ), Caproic acid (C 6 ), heptanoic acid (C 7 ), octanoic acid (C 8 ) and isomers thereof, such as ethyl 2-hexanoate (C 8 ), citric acid (C 9 ), citric acid (C 10 ) , dodecanoic acid (C 12 ), tetradecanoic acid (C 14 ), hexadecanoic acid (C 16 ), heptadecanoic acid (C 17 ), octadecanoic acid (C 18 ), eicosanoic acid (C 20 ), two Dodecanoic acid (C 22 ), tetracosic acid (C 24 ), hexadecanoic acid (C 26 ), octadecanoic acid (C 28 ), tridecanoic acid (C 30 ), etc., and not enumerated Isomers.

上述脂肪酸也能夠為不飽和脂肪酸。作為上述不飽和脂肪酸,有舉例如C3~C20之不飽和脂肪酸,例如單不飽和脂肪酸,例如巴豆酸(C4)、肉豆蔻油酸(C14)、棕櫚油酸(C16)、十八烯酸(C18)、反油酸(C18)、反11-十八烯酸(C18)、鱈油酸(C20)、二十烯酸(C20)等、二不飽和脂肪酸,例如亞油酸(C18)、二十碳二烯酸(C20)等、三不飽和脂肪酸,例如次亞麻油酸,例如α-次亞麻油酸(C18)以及γ-次亞麻油酸(C18)、松油酸(C18)、桐酸,例如α-桐酸(C18)以及β-桐酸(C18)、米德酸(C20)、二同-γ-次亞麻油酸(C20)、二十碳三烯酸(C20)等、四不飽和脂肪酸,例如十八碳四烯酸(C20)、花生四烯酸(C20)、花生油酸(C20)等、五不飽和脂肪酸,例如伯色五烯酸(bosseopentaenoic acid)(C18)、二十碳五烯酸(C20)等以及此等之部分氫加成物。 The above fatty acids can also be unsaturated fatty acids. Examples of the unsaturated fatty acid include C 3 to C 20 unsaturated fatty acids such as monounsaturated fatty acids such as crotonic acid (C 4 ), myristate oleic acid (C 14 ), palmitoleic acid (C 16 ), Octadecenoic acid (C 18 ), oleic acid (C 18 ), trans 11-octadecenoic acid (C 18 ), oleic acid (C 20 ), eicosenoic acid (C 20 ), etc., diunsaturated Fatty acids, such as linoleic acid (C 18 ), eicosadienoic acid (C 20 ), etc., triunsaturated fatty acids, such as linoleic acid, such as alpha-linolenic acid (C 18 ) and gamma-sub-Asia Sesic acid (C 18 ), pinoleic acid (C 18 ), tung acid, such as α-tungstic acid (C 18 ), and β-tungstic acid (C 18 ), metic acid (C 20 ), di-γ-γ- Sublinoleic acid (C 20 ), eicosatrienoic acid (C 20 ), etc., tetraunsaturated fatty acids such as stearidonic acid (C 20 ), arachidonic acid (C 20 ), peanut oleic acid ( C 20 ) Iso-penta-unsaturated fatty acids, such as bosseopentaenoic acid (C 18 ), eicosapentaenoic acid (C 20 ), and the like, and some of the hydrogen adducts thereof.

[(a2)鏈狀烴三元醇與至少1個脂肪酸之酯] [(a 2 ) an ester of a chain hydrocarbon triol with at least one fatty acid]

鏈狀烴三元醇意指上述鏈狀烴的氫原子(合計3個)被氫氧基(-OH)(合計3個)所取代之化合物,作為上述鏈狀烴三元醇與至少1個脂肪酸之酯,有舉例如下述式(5): 之丙三醇與脂肪酸之三酯、下述式(6): 之丙三醇與脂肪酸之二酯、以及下述式(7): (式中、R5~R7分別為鏈狀烴)之丙三醇與脂肪酸之單酯。 The chain hydrocarbon triol means a compound in which a hydrogen atom (total of three) of the above chain hydrocarbons is substituted with a hydroxyl group (-OH) (total of three) as the above chain hydrocarbon triol and at least one An ester of a fatty acid, for example, the following formula (5): The glycerol and fatty acid triester, the following formula (6): a diester of glycerol and a fatty acid, and the following formula (7): (wherein, R 5 to R 7 are each a chain hydrocarbon) are monoesters of glycerin and a fatty acid.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(a3)鏈狀烴二元醇與至少1個脂肪酸之酯] [(a 3 ) an ester of a chain hydrocarbon diol with at least one fatty acid]

上述鏈狀烴二元醇意指上述鏈狀烴之氫原子(合計2個)被氫氧基(-OH)(合計2個)所取代之化合物,作為上述鏈狀烴二元醇與至少1個脂肪酸之酯,有舉例如下述式(8):R8COOCkH2kOCOR9 (8) The above-mentioned chain hydrocarbon diol means a compound in which a hydrogen atom (total of two) of the above chain hydrocarbons is substituted by a hydroxyl group (-OH) (total of two) as the above chain hydrocarbon diol and at least 1 An ester of a fatty acid, for example, the following formula (8): R 8 COOC k H 2k OCOR 9 (8)

(式中,k為2~6之整數,且R8以及R9分別為鏈狀烴)之C2~C6乙二醇與脂肪酸之二酯、以及下述式(9):R8COOCkH2kOH (9) (wherein, k is an integer of 2 to 6, and R 8 and R 9 are each a chain hydrocarbon), a C 2 -C 6 ethylene glycol and a fatty acid diester, and the following formula (9): R 8 COOC k H 2k OH (9)

(式中,k為2~6之整數,且R8為鏈狀烴)之C2~C6乙二醇與脂肪酸之單酯。 (wherein, k is an integer of 2 to 6, and R 8 is a chain hydrocarbon) a monoester of a C 2 -C 6 ethylene glycol and a fatty acid.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(b1)鏈狀烴四元醇與至少1個脂肪族一元醇類之醚] [(b 1 ) ether of chain hydrocarbon tetraol and at least one aliphatic monohydric alcohol]

作為(b1)鏈狀烴四元醇與至少1個脂肪族一元醇類之醚,有舉例如下述式(10)~(13): Examples of the (b 1 ) chain hydrocarbon tetraol and at least one aliphatic monohydric alcohol ether include, for example, the following formulas (10) to (13):

(式中、R10~R13分別為鏈狀烴)。之季戊四醇與脂肪族一元醇類之四醚、三醚、二醚以及單 醚。 (wherein R 10 to R 13 are each a chain hydrocarbon). The tetraether, triether, diether and monoether of pentaerythritol and aliphatic monohydric alcohols.

且,鏈狀烴四元醇如以上所述。 Further, the chain hydrocarbon tetraol is as described above.

作為上述脂肪族一元醇類,有舉例如飽和脂肪族一元醇類以及不飽和脂肪族一元醇類。 Examples of the aliphatic monohydric alcohols include saturated aliphatic monohydric alcohols and unsaturated aliphatic monohydric alcohols.

作為上述飽和脂肪族一元醇類,有舉例如C1~C20之飽和脂肪族一元醇類,例如甲醇(C1)(C1表示碳數,以下相同)、乙醇(C2)、丙醇(C3)以及其異構物,例如異丙醇(C3)、丁醇(C4)以及其異構物,例如sec-丁醇(C4)以及tert-丁醇(C4)、戊醇(C5)、己醇(C6)、庚醇(C7)、辛醇(C8)以及其異構物、例如2-乙基己醇(C8)、壬醇(C9)、癸醇(C10)、十二醇(C12)、十四醇(C14)、十六醇(C16)、十七醇(C17)、十八醇(C18)、以及二十醇(C20)、以及沒有被列舉的此等異構物。 Examples of the saturated aliphatic monohydric alcohols include, for example, C 1 to C 20 saturated aliphatic monohydric alcohols, for example, methanol (C 1 ) (C 1 represents a carbon number, the same applies hereinafter), ethanol (C 2 ), and propanol. (C 3 ) and its isomers, such as isopropanol (C 3 ), butanol (C 4 ), and isomers thereof, such as sec-butanol (C 4 ) and tert-butanol (C 4 ), pentanol (C 5), hexyl alcohol (C 6), heptyl alcohol (C 7), octyl (C 8) and isomers thereof, e.g. 2-ethyl hexanol (C 8), nonyl alcohol (C 9 ), decyl alcohol (C 10 ), dodecyl alcohol (C 12 ), tetradecyl alcohol (C 14 ), cetyl alcohol (C 16 ), heptadecyl alcohol (C 17 ), stearyl alcohol (C 18 ), and Decanol (C 20 ), and such isomers not listed.

作為上述不飽和脂肪族一元醇類為將上述飽和脂肪族一元醇類的1個C-C單鍵以C=C雙鍵所取代者,有舉例如油醇。 The unsaturated aliphatic monohydric alcohol is one in which one C-C single bond of the above saturated aliphatic monohydric alcohol is substituted by a C=C double bond, and examples thereof include oleyl alcohol.

[(b2)鏈狀烴三元醇與至少1個脂肪族一元醇類之醚] [(b 2 ) ether of chain hydrocarbon triol and at least one aliphatic monohydric alcohol]

作為(b2)鏈狀烴三元醇與至少1個脂肪族一元醇類之醚,有舉例如下述式(14)~(16): Examples of the (b 2 ) chain hydrocarbon triol and at least one aliphatic monohydric alcohol ether include the following formulas (14) to (16):

(式中、R14~R16分別為鏈狀烴)。之丙三醇與脂肪族一元醇類之三醚、二醚以及單醚。 (wherein R 14 to R 16 are each a chain hydrocarbon). The tris, diether and monoether of glycerol and aliphatic monohydric alcohols.

且,鏈狀烴三元醇以及脂肪族一元醇類如以上所述。 Further, the chain hydrocarbon triol and the aliphatic monohydric alcohol are as described above.

[(b3)鏈狀烴二元醇與至少1個脂肪族一元醇類之醚] [(b 3 ) an ether of a chain hydrocarbon diol and at least one aliphatic monohydric alcohol]

作為(b3)鏈狀烴二元醇與至少1個脂肪族一元醇類之醚,有舉例如下述式(17):R17OCnH2nOR18 (17) As the ether of the (b 3 ) chain hydrocarbon diol and at least one aliphatic monohydric alcohol, for example, the following formula (17): R 17 OC n H 2n OR 18 (17)

(式中,n為2~6之整數,且R17以及R18分別為鏈狀烴)之C2~C6乙二醇與脂肪族一元醇類之二醚、以及下述式(18):R17OCnH2nOH (18) (wherein, n is an integer of 2 to 6, and R 17 and R 18 are each a chain hydrocarbon), a diether of a C 2 -C 6 ethylene glycol and an aliphatic monohydric alcohol, and the following formula (18) :R 17 OC n H 2n OH (18)

(式中,n為2~6之整數,且R17為鏈狀烴)之C2~C6乙二醇與脂肪族一元醇類之單醚。 (wherein, n is an integer of 2 to 6, and R 17 is a chain hydrocarbon) a monoether of C 2 -C 6 ethylene glycol and an aliphatic monohydric alcohol.

且,鏈狀烴二元醇以及脂肪族一元醇類如以上所述。 Further, the chain hydrocarbon diol and the aliphatic monohydric alcohol are as described above.

[(c1)具有4個羧基的鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯]。 [(c 1 ) a chain hydrocarbon tetracarboxylic acid having four carboxyl groups, a hydroxy acid, an alkoxy acid or an ester of an oxo acid and at least one aliphatic monohydric alcohol].

作為(c1)具有4個羧基的鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯、二酯、三酯以及四酯。 And (c 1 ) an ester of a chain hydrocarbon tetracarboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid having at least one carboxyl group and at least one aliphatic monohydric alcohol, for example, a monoester, a diester or a triester thereof. And tetraester.

[(c2)具有3個羧基的鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯]。 [(c 2 ) a chain hydrocarbon tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an ester of an oxo acid and at least one aliphatic monohydric alcohol].

作為(c2)具有3個羧基的鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯、二酯以及三酯。 And (c 2 ) an ester of a chain hydrocarbon tricarboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid having at least three carboxyl groups and at least one aliphatic monohydric alcohol, for example, a monoester, a diester thereof and a triester thereof. .

[(c3)具有2個羧基的鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯]。 [(c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an ester of an oxo acid and at least one aliphatic monohydric alcohol].

作為(c3)具有2個羧基的鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸與至少1個脂肪族一元醇類之酯,有舉例如其單酯以及二酯。 The ester of (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid and at least one aliphatic monohydric alcohol may, for example, be a monoester or a diester.

[(d1)脂肪族一元醇類與脂肪族一元醇類之醚] [(d 1 ) Ether of aliphatic monohydric alcohols and aliphatic monohydric alcohols]

脂肪族一元醇類如以上所述,作為上述脂肪族一元醇類與脂肪族一元醇類之醚,有舉出具有下述式(19):R19OR20 (19) The aliphatic monohydric alcohol is as described above, and as the ether of the above aliphatic monohydric alcohol and aliphatic monohydric alcohol, there is a formula (19): R 19 OR 20 (19)

(式中,R19以及R20分別為鏈狀烴) 之化合物。 (wherein, R 19 and R 20 are each a chain hydrocarbon).

且,鏈狀烴如以上所述。 Further, the chain hydrocarbons are as described above.

[(d2)二烷基酮] [(d 2 )dialkyl ketone]

作為上述二烷基酮,有舉出具有下述式(20):R21COR22 (20) The dialkyl ketone is exemplified by the following formula (20): R 21 COR 22 (20)

(式中,R21以及R22分別為烷基)之化合物。 A compound of the formula (wherein R 21 and R 22 are each an alkyl group).

[(d3)脂肪酸與脂肪族一元醇類之酯] [(d 3 ) ester of fatty acid with aliphatic monohydric alcohol]

脂肪酸以及脂肪族一元醇類如以上所述,作為上述脂肪酸與脂肪族一元醇類之酯,有舉例如具有下述式(21):R23COOR24 (21) The fatty acid and the aliphatic monohydric alcohol are as described above, and as the ester of the above fatty acid and the aliphatic monohydric alcohol, for example, the following formula (21): R 23 COOR 24 (21)

(式中,R23以及R24分別為鏈狀烴)之化合物。 A compound of the formula (wherein R 23 and R 24 are each a chain hydrocarbon).

且,鏈狀烴如以上所述。 Further, the chain hydrocarbons are as described above.

[(d4)二烷基碳酸酯] [(d 4 )Dialkyl carbonate]

作為上述二烷基碳酸酯,有舉出具有下述式(22):R25OC(=O)OR26 (22) As the above dialkyl carbonate, there is a formula (22): R 25 OC(=O)OR 26 (22)

(式中,R25以及R26分別為烷基)之化合物。 A compound of the formula (wherein R 25 and R 26 are each an alkyl group).

[(e1)聚氧C3~C6烷二醇] [(e 1 ) polyoxy C 3 ~C 6 alkanediol]

上述聚氧C3~C6烷二醇意指i)具有氧基C3~C6伸烷基骨架,亦即具有選自氧基丙烯骨架、氧基丁烯骨架、氧基戊烯骨架以及氧基己烯骨架所成群中之任1種骨架,且在兩末端具有羥基之同元共聚物、ii)具有選自上述群中之2種以上的骨架,且在兩末端具有羥基之嵌段共聚合物、或iii)具有選自上述群中之2種以上的骨架,且在兩末端具有羥基之無規共聚物。 The above polyoxy C 3 -C 6 alkanediol means i) having an oxy C 3 -C 6 alkylene skeleton, that is, having an oxypropylene skeleton, an oxybutene skeleton, an oxypentene skeleton, and Any one of a skeleton in which a oxyhexene skeleton is grouped, and a homopolymer having a hydroxyl group at both terminals, ii) having two or more kinds of skeletons selected from the above group, and having a hydroxyl group at both ends A segment copolymer, or iii) a random copolymer having two or more skeletons selected from the above group and having a hydroxyl group at both terminals.

上述聚氧C3~C6烷二醇以下述式(23):HO-(CmH2mO)n-H (23) The above polyoxy C 3 -C 6 alkanediol is represented by the following formula (23): HO-(C m H 2m O) n -H (23)

(式中,m為3~6之整數)所表示。 (where m is an integer from 3 to 6).

[(e2)聚氧C3~C6烷二醇與至少1個脂肪酸之酯] [(e 2 ) an ester of polyoxy C 3 -C 6 alkanediol with at least one fatty acid]

作為上述聚氧C3~C6烷二醇與至少1個脂肪酸之酯,有舉出「(e1)聚氧C3~C6烷二醇」之項中所說明的聚氧C3~C6烷二醇之OH末端的一方或雙方經脂肪酸酯化者,亦即,單酯以及二酯。 Examples of the polyoxy C 3 ~ C 6 alkylene glycol and at least one ester of fatty acid, there are mentioned "(e 1) polyoxy C 3 ~ C 6 alkanediol" as described in Paragraph C 3 ~ polyoxy One or both of the OH ends of the C 6 alkanediol are esterified with a fatty acid, that is, a monoester and a diester.

且,關於脂肪酸如以上所述。 Further, the fatty acid is as described above.

[(e3)聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚] [(e 3 ) an ether of a polyoxy C 3 -C 6 alkanediol and at least one aliphatic monohydric alcohol]

作為上述聚氧C3~C6烷二醇與至少1個脂肪族一元醇類之醚,有舉出「(e1)聚氧C3~C6烷二醇」之項中所說明的聚氧C3~C6烷二醇之OH末端的一方或雙方經脂肪族一 元醇類醚化者,亦即單醚以及二醚。 The polyoxy C 3 -C 6 alkanediol and at least one aliphatic monohydric alcohol are exemplified by the "(e 1 ) polyoxy C 3 -C 6 alkanediol". One or both of the OH ends of the oxygen C 3 -C 6 alkanediol are etherified with an aliphatic monohydric alcohol, that is, a monoether and a diether.

且,關於脂肪族一元醇類,有如以上所述。 Further, regarding the aliphatic monohydric alcohol, it is as described above.

體液滑性賦予劑之作用是如國際公開第2012/133724號說明書、國際公開第2013/129236號說明書等中所說明,但上述膠體乳液中包含作為乳液的體液滑性賦予劑時,能進一步得到以下之作用。 The action of the body fluid slip imparting agent is as described in the specification of International Publication No. 2012/133724 and the specification of International Publication No. 2013/129236. However, when the colloidal emulsion contains a body fluid slip imparting agent as an emulsion, it can be further obtained. The following effects.

上述膠體乳液會連續地釋放出體液滑性賦予劑至吸收性物品之肌膚接觸區域,例如,由於是緩緩釋放出,即使體液滑性賦予劑與體液一起滑落到吸收性物品內部,新的體液滑性賦予劑也會再從膠體乳液被供給至液體透過性層之表面,並使體液繼續滑落到吸收性物品內部。其結果,即使長時間連續使用吸收性物品時,液體透過性層也難以產生沾黏感,液體透過性層會繼續保持在乾爽狀態。 The above colloidal emulsion continuously releases the body fluid slip imparting agent to the skin contact area of the absorbent article, for example, because it is slowly released, even if the body fluid slip imparting agent slides down into the absorbent article together with the body fluid, the new body fluid The slip imparting agent is also supplied from the colloidal emulsion to the surface of the liquid permeable layer, and the body fluid continues to slide down into the interior of the absorbent article. As a result, even when the absorbent article is continuously used for a long period of time, the liquid permeable layer is less likely to have a sticky feeling, and the liquid permeable layer continues to be in a dry state.

上述乳液中較佳為包含0~50質量%,再較佳為包含0~40質量%,且更較佳為0~30質量%之上述體液滑性賦予劑。這是以膠體形成之觀點來看。 The above emulsion preferably contains 0 to 50% by mass, more preferably 0 to 40% by mass, and still more preferably 0 to 30% by mass of the above-mentioned body fluid slip imparting agent. This is in terms of colloid formation.

上述膠體乳液中基於此等之合計100質量份,較佳分別以1~30質量份以及70~99質量份,再較佳分別以2~20質量份以及80~98質量份,且更較佳分別以3~15質量份以及85~97質量份之比率包含膠體化劑與乳液。上述膠體化劑之比率若低於1質量份,則所形成之膠體乳液會難以具有彈性體之作用,或是當施加體壓時會有超過膠體乳液之彈性界限而變形的情況。上述膠體化劑之 比率若超過30質量份,則所形成之膠體乳液的彈性會變高,有時著用感會變差。 The above-mentioned colloidal emulsion is preferably used in an amount of from 1 to 30 parts by mass and from 70 to 99 parts by mass, more preferably from 2 to 20 parts by mass and from 80 to 98 parts by mass, and more preferably, based on 100 parts by mass of the total of the above-mentioned colloidal emulsions. The colloidizing agent and the emulsion are contained in a ratio of 3 to 15 parts by mass and 85 to 97 parts by mass, respectively. When the ratio of the above colloidizing agent is less than 1 part by mass, the formed colloidal emulsion may have difficulty in functioning as an elastomer or may be deformed when the body pressure is applied, which exceeds the elastic limit of the colloidal emulsion. The above colloidal agent When the ratio exceeds 30 parts by mass, the elasticity of the formed colloidal emulsion becomes high, and the feeling of use may be deteriorated.

上述膠體乳液具有1~100kPa之50%變形時的壓縮應力,較佳為具有1~80kPa之50%變形時的壓縮應力,再較佳為具有1.5~60kPa之50%變形時的壓縮應力。 The colloidal emulsion has a compressive stress at 50% deformation of 1 to 100 kPa, preferably a compressive stress at 50% deformation of 1 to 80 kPa, and more preferably a compressive stress at 50% deformation of 1.5 to 60 kPa.

50%變形時的壓縮應力若低於1kPa,則施加體壓時會有膠體乳液超過彈性界限而變形,並有被破壞的情況,且50%變形時的壓縮應力若超過100kPa,則膠體乳液之彈性會變高,施加體壓時膠體乳液會難以變形,著用者會有察覺到違和感之情況。 When the compressive stress at 50% deformation is less than 1 kPa, when the body pressure is applied, the colloidal emulsion is deformed beyond the elastic limit and is broken, and if the compressive stress at 50% deformation exceeds 100 kPa, the colloidal emulsion is The elasticity will become high, and the colloidal emulsion will be difficult to deform when the body pressure is applied, and the user will perceive the feeling of discomfort.

以往的乳液塗覆、護膚劑等,為了將有效成分固定在特定的地方,採用將此等高黏度化(黏性體化)之手法。然而,將此等高黏度化之後,有效成分(柔軟劑等)會被鎖在乳液塗覆、護膚劑等之內部,變得難以發揮其機能。且,以往的乳液塗覆、護膚劑等,只是黏性體,若施加著壓等體壓,會有無法固定於特定的地方,,移動到吸收性物品內部,難以持續對著用者之肌膚作用的問題點。 Conventional emulsion coatings, skin care agents, and the like, in order to fix an active ingredient in a specific place, a method of making such a high viscosity (viscosity) is employed. However, after such high viscosity, the active ingredient (softener, etc.) is locked inside the emulsion coating, the skin care agent, etc., and it becomes difficult to exert its function. In addition, conventional emulsion coatings, skin care agents, and the like are only viscous bodies. If a body pressure such as pressure is applied, they may not be fixed to a specific place, and may move to the inside of the absorbent article, and it is difficult to continue to face the user's skin. The problem point.

另一方面,上述膠體乳液會在有施加體壓等之範圍內表現作為彈性體之現象。因此,即使對上述膠體乳液施加較高的體壓,也會一直停留在彈性變形,且不會被擠壓至頂部薄片的纖維等之間,而在體壓變低之後,彈性會回復,並回到原本的位置(肌膚接觸區域)。因此,膠體乳液中所包含之乳液能夠在所期望的位置中達成其作用。 On the other hand, the above-mentioned colloidal emulsion exhibits a phenomenon as an elastomer in a range in which a body pressure or the like is applied. Therefore, even if a high body pressure is applied to the above-mentioned colloidal emulsion, it will remain elastically deformed and will not be squeezed between the fibers of the top sheet, etc., and after the body pressure becomes low, the elasticity will recover, and Return to the original position (skin contact area). Therefore, the emulsion contained in the colloidal emulsion can achieve its effect in the desired position.

本說明書中,膠體乳液之50%變形時的壓縮應力如以下所述來測定。 In the present specification, the compressive stress at the time of 50% deformation of the colloidal emulsion is measured as described below.

且,沒有特別規定之事項是根據JIS K 7181:2011「塑膠-壓縮特性之求出方法」之「3.7 x%變形時的壓縮應力」。 Further, the item which is not specified is the "compressive stress at 3.7 x% deformation" according to JIS K 7181:2011 "Method for Deriving Plastic-Compression Characteristics".

(1)在20℃ 65%RH之恆溫恆濕室中準備壓縮試驗機。 (1) A compression tester was prepared in a constant temperature and humidity chamber at 20 ° C and 65% RH.

且,本實施例中,作為壓縮試驗機,使用小型桌上型試驗機EzTest(島津製作所製)。 Further, in the present embodiment, a small table type tester EzTest (manufactured by Shimadzu Corporation) was used as the compression tester.

(2)在壓縮試驗機上裝置壓縮用模具。 (2) A mold for compression is mounted on a compression tester.

且,本實施例中,使用直徑120mm之不銹鋼製壓縮用模具。 Further, in the present embodiment, a stainless steel compression mold having a diameter of 120 mm was used.

(3)在壓縮用模具中裝置膠體乳液。 (3) A colloidal emulsion is placed in a mold for compression.

且,本實施例中,準備具有直徑為40mm且高度為8mm的圓筒形之膠體乳液。 Further, in the present embodiment, a cylindrical colloidal emulsion having a diameter of 40 mm and a height of 8 mm was prepared.

(4)以5mm/分之壓縮速度,將膠體乳液壓縮至壓縮量為4mm,亦即變形為50%為止,讀取壓縮力(N)。 (4) The colloidal emulsion was compressed at a compression speed of 5 mm/min. to a compression amount of 4 mm, that is, a deformation of 50%, and the compression force (N) was read.

(5)將壓縮力(N)換算成壓縮應力(Pa)。 (5) The compression force (N) is converted into a compressive stress (Pa).

且,壓縮應力是採用相異的樣本實施3次測定值的平均值。 Further, the compressive stress is an average value of three measured values performed using different samples.

[抗磨劑] [anti-wear agent]

上述膠體乳液除了膠體化劑以及乳液之外,能夠進一步包含抗磨劑。作為上述抗磨劑,有舉例如矽油、矽系樹脂、丙烯酸烷酯共聚合物、界面活性劑、長鏈脂肪族酯 等。上述膠體乳液藉由包含抗磨劑,能夠期待在著用時,膠體乳液與著用者肌膚之間的摩擦變少,且著用者肌膚較不容易起疹之效果。 The above colloidal emulsion can further contain an anti-wear agent in addition to the colloidizing agent and the emulsion. As the anti-wear agent, for example, eucalyptus oil, lanthanum resin, alkyl acrylate copolymer, surfactant, long-chain aliphatic ester Wait. By including an anti-wear agent, the colloidal emulsion can be expected to have less friction between the colloidal emulsion and the skin of the user when it is used, and the skin of the user is less likely to have a rash effect.

上述膠體乳液較佳為具有0.01~1.00,再較佳為具有0.02~0.50,且更較佳為具有0.03~0.03之靜磨擦係數。這是以著用者肌膚較難起疹的程度之觀點來看。 The above colloidal emulsion preferably has a static friction coefficient of from 0.01 to 1.00, more preferably from 0.02 to 0.50, and still more preferably from 0.03 to 0.03. This is in view of the extent to which the user's skin is more difficult to rash.

為了達成上述靜磨擦係數,膠體乳液中,相對於膠體乳液100質量份(膠體化劑以及乳液之合計100質量份),較佳以0.01~20質量份,再較佳以0.05~10質量份,且再較佳以0.1~7質量份之量包含上述抗磨劑。 In order to achieve the static friction coefficient, the colloidal emulsion is preferably 0.01 to 20 parts by mass, more preferably 0.05 to 10 parts by mass, per 100 parts by mass of the colloidal emulsion (100 parts by mass of the colloidal agent and the emulsion). Further preferably, the above anti-wear agent is contained in an amount of 0.1 to 7 parts by mass.

上述靜磨擦係數如以下所述來測定。且,測定是在20℃×65%RH之恆溫恆濕室下進行。 The above static friction coefficient was measured as described below. Further, the measurement was carried out in a constant temperature and humidity chamber at 20 ° C × 65% RH.

(1)準備具有直徑為40mm且高度為8mm的圓筒形之膠體乳液。 (1) A cylindrical colloidal emulsion having a diameter of 40 mm and a height of 8 mm was prepared.

(2)作為靜磨擦試驗機,準備HEIDON摩擦測定機μs(MUSE)TYPE:94i(以下有時略稱為「MUSE」)。 (2) As a static friction tester, a HEIDON friction measuring machine μs (MUSE) TYPE: 94i (hereinafter sometimes referred to as "MUSE") is prepared.

(3)MUSE之本體有裝置滑件。 (3) The body of MUSE has a device slider.

(4)打開MUSE之電源,確認顯示為“0.00”。 (4) Turn on the power of MUSE and confirm that the display is "0.00".

(5)在膠體乳液上裝上MUSE之滑件。 (5) Mount the MUSE slider on the colloidal emulsion.

(6)按下MUSE的測定鈕,讀取所顯示之值。 (6) Press the MUSE measurement button to read the displayed value.

(7)測定為在相異的膠體乳液中實施合計5次,並採用此等的平均值。 (7) The measurement was carried out 5 times in a different colloidal emulsion, and the average value of these was used.

上述膠體乳液在不損害本發明之效果的範圍內,能夠包含其他成分。 The above colloidal emulsion can contain other components within a range that does not impair the effects of the present invention.

作為上述其他成分,有舉例如抗氧化劑,例如BHT(2,6-二-t-丁基-p-甲酚)、BHA(丁基化羥基甲氧苯酚)、沒食子酸丙酯等。 Examples of the other components include antioxidants such as BHT (2,6-di-t-butyl-p-cresol), BHA (butylated hydroxymethoxyphenol), and propyl gallate.

作為上述其他成分,有舉例如維他命,例如天然維他命或合成維他命。作為上述維他命,有舉例如水溶性維他命,例如維他命B群,例如維他命B1、維他命B2、維他命B3、維他命B5、維他命B6、維他命B7、維他命B9、維他命B12等、維他命C。 As the other ingredients mentioned above, for example, vitamins such as natural vitamins or synthetic vitamins are mentioned. As the above vitamins, for example, water-soluble vitamins such as vitamin B group, such as vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 9 , vitamin B 12 , etc., vitamins C.

作為上述維他命,有舉例如脂溶性維他命,例如維他命A群、維他命D群、維他命E群以及維他命K群等。 As the above-mentioned vitamins, for example, fat-soluble vitamins such as a vitamin A group, a vitamin D group, a vitamin E group, and a vitamin K group are mentioned.

上述維他命中亦包含此等之衍生物。 These vitamins also contain such derivatives.

作為上述其他成分,有舉例如胺基酸,例如丙氨酸、精胺酸、賴胺酸、組胺酸、脯氨酸、氫脯胺酸等以及胜肽。 Examples of the other components include amino acids such as alanine, arginine, lysine, histidine, proline, hydroquinone, and the like.

作為上述其他成分,例如沸石,例如天然沸石,例如方沸石、菱沸石、輝沸石、鈉沸石、束沸石以及杆沸石(thomosonite)、以及合成沸石。 As the above other components, for example, zeolites such as natural zeolites such as analcime, chabazite, stilbite, sodium zeolite, bundled zeolite, and thomasonite, and synthetic zeolites.

作為上述至少1種其他成分,有舉例如膽固醇、玻尿酸、卵磷脂、神經醯胺等。 Examples of the at least one other component include cholesterol, hyaluronic acid, lecithin, and neural amide.

且,作為上述其他成分,有舉例如藥劑,例如皮膚收斂劑、抗痘劑、抗皺劑、消皮下脂肪劑、美白劑、抗菌劑、抗霉劑等。 Further, examples of the other components include a drug such as a skin astringent, an anti-cree agent, an anti-wrinkle agent, a subcutaneous fat, a whitening agent, an antibacterial agent, and an antifungal agent.

作為上述皮膚收斂劑,有舉例如氧化鋅、硫酸鋁、單寧酸等、油溶性皮膚收斂劑,例如油溶性多酚。作為上述 油溶性多酚,有舉出天然的油溶性多酚,例如黃柏樹皮萃取物、金絲桃屬萃取物、蕁麻萃取物、洋甘菊萃取物、牛蒡萃取物、鼠尾草萃取物、菩提樹萃取物、西洋菩提樹萃取物、樺樹萃取物、木賊萃取物、藥用鼠尾草萃取物、鼠尾草萃取物、羌桃萃取物、木槿屬萃取物、枇杷葉萃取物、椴樹萃取物、啤酒花萃取物、甜栗萃取物、薏苡仁萃取物等。 Examples of the skin astringent agent include oil-soluble skin astringents such as zinc oxide, aluminum sulfate, and tannic acid, and oil-soluble polyphenols. As above Oil-soluble polyphenols, such as natural oil-soluble polyphenols, such as cork bark extract, hypericum extract, castor extract, chamomile extract, burdock extract, sage extract, linden extract, Western Linden Tree Extract, Birch Extract, Equisetum Extract, Medicinal Sage Extract, Clary Extract, Peach Extract, Hibiscus Extract, Loquat Leaf Extract, Eucalyptus Extract, Hop Extract , sweet chestnut extract, coix seed extract, etc.

作為上述抗痘劑,有舉例如水楊酸、過氧化苯甲醯、間苯二酚、硫、紅黴素、鋅等。 Examples of the anti-acne agent include salicylic acid, benzammonium peroxide, resorcinol, sulfur, erythromycin, zinc, and the like.

作為上述抗皺劑,有舉例如乳酸、水楊酸、水楊酸衍生物、乙二醇酸、植酸、硫辛酸、溶血磷脂酸(lysophosphatidic acid)。 Examples of the anti-wrinkle agent include lactic acid, salicylic acid, a salicylic acid derivative, glycolic acid, phytic acid, lipoic acid, and lysophosphatidic acid.

作為上述消皮下脂肪劑,有舉例如黃呤嘌化合物,例如胺基非林、咖啡因、茶鹼、可可鹼等。 As the above-mentioned subcutaneous fat-reducing agent, for example, a xanthine compound such as aminylline, caffeine, theophylline, theobromine or the like can be mentioned.

作為上述美白劑,有舉例如菸酸、麴酸、熊果素、葡萄胺糖以及衍生物、植物固醇衍生物、抗壞血酸以及其衍生物、以及桑樹萃取物以及胎盤萃取物。 As the above whitening agent, for example, nicotinic acid, citric acid, arbutin, glucosamine and derivatives, phytosterol derivatives, ascorbic acid and derivatives thereof, and mulberry extract and placenta extract are mentioned.

且,作為上述其他成分,有舉例如消炎成分、pH調整劑、抗菌劑、保濕劑、香料,例如香味油、色素、染料、顏料、植物萃取物等。作為上述消炎成分,有舉例如來自天然的消炎劑,例如牡丹、黃苓、金絲桃屬、洋甘菊、甘草、桃花、洋艾草、紫蘇萃取物等、合成消炎劑,例如尿囊素、甘草酸二鉀等。 Further, examples of the other components include an anti-inflammatory component, a pH adjuster, an antibacterial agent, a moisturizer, and a fragrance such as a flavor oil, a coloring matter, a dye, a pigment, and a plant extract. As the anti-inflammatory component, for example, natural anti-inflammatory agents such as peony, scutellaria, hypericum, chamomile, licorice, peach, wormwood, perilla extract, etc., synthetic anti-inflammatory agents such as allantoin, licorice Dipotassium acid and the like.

作為上述pH調整劑,有舉出用來將皮膚保持在弱酸 性者,例如蘋果酸、丁二酸、枸櫞酸、酒石酸、乳酸等。 As the above pH adjusting agent, it is mentioned to keep the skin weakly acidic Sex, such as malic acid, succinic acid, citric acid, tartaric acid, lactic acid, and the like.

作為上述顏料,有舉例如氧化鈦。 As the above pigment, for example, titanium oxide is mentioned.

且,作為上述其他成分,有舉出具有護膚作用者,例如荷荷芭油、苦茶油以及鯊烷油。 Further, as the other components mentioned above, there are those having a skin care function, such as jojoba oil, bitter tea oil, and squalane oil.

且,作為上述其他成分,有舉出石油。 Further, as the other components mentioned above, petroleum is mentioned.

本發明之吸收性物品能夠在與著用者肌膚接觸的任意面上具有上述膠體乳液,例如在吸收性層之肌膚接觸區域中具有上述膠體乳液。 The absorbent article of the present invention can have the above-mentioned colloidal emulsion on any surface that comes into contact with the skin of the user, and for example, has the above-mentioned colloidal emulsion in the skin contact region of the absorbent layer.

本發明之吸收性物品中,對膠體乳液的配置並無特別限制,例如在液體透過性層之肌膚接觸區域中配置成線狀或點狀。 In the absorbent article of the present invention, the arrangement of the colloidal emulsion is not particularly limited, and for example, it is arranged in a line shape or a dot shape in the skin contact region of the liquid permeable layer.

圖1表示根據本發明實施形態的1個吸收性物品1之平面圖。圖1中所示之吸收性物品1,更具體來說生理用衛生棉中具有作為液體透過性層之頂部薄片2、與作為液體不透過性層之底部薄片(無圖示)、與在頂部薄片2以及底部薄片(無圖示)之間作為吸收性層之吸收體3。圖1中所示之吸收性物品1亦具有側邊薄片4與壓印部5。 Fig. 1 is a plan view showing an absorbent article 1 according to an embodiment of the present invention. The absorbent article 1 shown in Fig. 1, more specifically, the sanitary napkin has a top sheet 2 as a liquid permeable layer, a bottom sheet as a liquid impermeable layer (not shown), and a top portion. An absorbent body 3 serving as an absorbent layer between the sheet 2 and the bottom sheet (not shown). The absorbent article 1 shown in Fig. 1 also has a side sheet 4 and an embossing portion 5.

頂部薄片2在其肌膚接觸區域中包含膠體乳液6,且複數個線狀膠體乳液6是延著吸收性物品1之縱向方向被塗佈。換而言之,頂部薄片2中包含互相平行且往吸收性物品1之縱向方向延伸之複數個線狀膠體乳液6。 The top sheet 2 contains a colloidal emulsion 6 in its skin contact area, and a plurality of linear colloidal emulsions 6 are applied in the longitudinal direction of the absorbent article 1. In other words, the top sheet 2 contains a plurality of linear colloidal emulsions 6 which are parallel to each other and extend in the longitudinal direction of the absorbent article 1.

圖2表示根據有別於本發明實施形態之吸收 性物品1的平面圖。圖2所表示之吸收性物品1,更具體來說為生理用衛生棉中,頂部薄片2在其肌膚接觸區域中包含膠體乳液6,且複數個點狀膠體乳液6被塗佈成千鳥狀。換而言之,頂部薄片2中包含被配置成千鳥狀的複數個點狀膠體乳液6。 Figure 2 shows absorption according to an embodiment different from the present invention. Plan view of the sexual item 1. In the absorbent article 1 shown in Fig. 2, more specifically, in a sanitary napkin, the top sheet 2 contains a colloidal emulsion 6 in its skin contact area, and a plurality of point-like colloidal emulsions 6 are coated in a thousand birds. In other words, the top sheet 2 contains a plurality of point-like colloidal emulsions 6 arranged in a thousand bird shape.

本發明之吸收性物品中,關於塗佈有上述膠體乳液之面積並無特別限制,但以不阻礙吸收性物品的通氣性之觀點來看,與著用者肌膚接觸的區域中,較佳為塗佈1~50%,再較佳為塗佈3~40%,且更較佳為塗佈5~30%之區域。 In the absorbent article of the present invention, the area in which the colloidal emulsion is applied is not particularly limited, but it is preferably in a region in contact with the user's skin from the viewpoint of not impeding the air permeability of the absorbent article. The coating is 1 to 50%, more preferably 3 to 40%, and more preferably 5 to 30%.

且,在液體透過性層中塗佈有上述膠體乳液之實施形態中,上述膠體乳液,在液體透過性層與吸收性層在吸收性物品的厚度方向上重複的範圍之內,被塗佈為液體透過性層面積之1~50%的區域較佳,被塗佈為液體透過性層面積之3~40%的區域再較佳,且被塗佈為液體透過性層面積之5~30%的區域更較佳。 In the embodiment in which the colloidal emulsion is applied to the liquid permeable layer, the colloidal emulsion is applied as a range in which the liquid permeable layer and the absorbent layer are repeated in the thickness direction of the absorbent article. A region of 1 to 50% of the area of the liquid permeable layer is preferably used, and a region coated with 3 to 40% of the area of the liquid permeable layer is more preferably 5 to 30% of the area of the liquid permeable layer. The area is better.

若上述膠體乳液塗佈未滿液體透過性層面積之1%,則會有難以發揮本發明效果之傾向。若上述膠體乳液塗佈超過液體透過性層面積之50%的區域時,由於塗佈有膠體乳液的區域不會吸收體液,作為其結果,吸收體液的區域會變窄,吸收性會有降低之傾向。 When the above-mentioned colloidal emulsion coating is less than 1% of the area of the liquid permeable layer, it is difficult to exhibit the effects of the present invention. When the colloidal emulsion is applied in a region exceeding 50% of the area of the liquid permeable layer, the body fluid is not absorbed in the region where the colloidal emulsion is applied, and as a result, the region in which the body fluid is absorbed is narrowed, and the absorbability is lowered. tendency.

且,為了達成上述塗佈區域,液體透過性層與吸收性層在吸收性物品厚度方向上重複的範圍之內,較佳為以1~30g/m2,再較佳為以2~20g/m2,且更較佳為以 3~10g/m2之基重包含上述膠體乳液。 Further, in order to achieve the coating region, the liquid permeable layer and the absorbent layer are preferably in the range of 1 to 30 g/m 2 , more preferably 2 to 20 g / in the range in which the absorbent article is repeated in the thickness direction of the absorbent article. m 2 , and more preferably contains the above colloidal emulsion at a basis weight of 3 to 10 g/m 2 .

本說明書中,膠體乳液之基重如以下來測定。 In the present specification, the basis weight of the colloidal emulsion is measured as follows.

(1)將頂部薄片之應測定的範圍以銳利的刀具,例如刀片的替換刀片切出,得到樣品。 (1) The range to be measured of the top sheet is cut out with a sharp blade such as a replacement blade of the blade to obtain a sample.

(2)樣品之面積:測定A(m2)以及質量:M0(g)。 (2) Area of sample: Determination of A (m 2 ) and mass: M 0 (g).

(3)將樣品在膠體乳液為可溶之溶媒,例如芳香族系溶媒,例如二甲苯等之中,至少攪拌3分鐘,使膠體乳液溶解於溶媒中。 (3) The sample is stirred at least for 3 minutes in a solvent in which the colloidal emulsion is soluble, for example, an aromatic solvent such as xylene, and the colloidal emulsion is dissolved in the solvent.

(4)將樣品在已測定質量的濾紙上進行過濾,在濾紙上,以溶媒將樣品充分洗淨。將濾紙上之樣品於100℃之烘箱內進行乾燥。 (4) The sample was filtered on the filter paper of the measured mass, and the sample was thoroughly washed with a solvent on the filter paper. The sample on the filter paper was dried in an oven at 100 °C.

(5)測定濾紙以及樣品之質量,藉由由此減去濾紙的質量,算出乾燥後之樣品質量:M1(g)。 (5) The mass of the filter paper and the sample were measured, and the mass of the dried sample was calculated by subtracting the mass of the filter paper: M 1 (g).

(6)將膠體乳液之基重GBW(g/m2)以下述式:GBW(g/m2)=[M0(g)-M1(g)]/A(m2)算出。 (6) Calculating the basis weight G BW (g/m 2 ) of the colloidal emulsion by the following formula: G BW (g/m 2 )=[M 0 (g)-M 1 (g)]/A(m 2 ) .

且,為了減少誤差,自複數吸收性物品中採取複數樣品使樣品之總面積超過100cm2,重複複數次實驗,採用其平均值。 Further, in order to reduce the error, a plurality of samples were taken from the complex absorbent article so that the total area of the sample exceeded 100 cm 2 , and the experiment was repeated for a plurality of experiments, and the average value thereof was used.

本發明之吸收性物品中,液體透過性層為不織布或織布時,該不織布或織布以親水化處理過較佳。作為上述親水化處理,有舉出在不織布或織布纖維的表面上塗覆親水劑、對不織布或織布的原料之合成樹脂中混合親 水劑等。在液體透過性層上成為交雜地共存來自烴基、體液滑性賦予劑等之親油性區域、與來自親水劑之親水性區域,而更能發揮滑落性能,這是因為使體液容易迅速地移動至吸收體。 In the absorbent article of the present invention, when the liquid permeable layer is a nonwoven fabric or a woven fabric, the nonwoven fabric or woven fabric is preferably hydrophilized. As the hydrophilization treatment, there is a synthetic resin in which a hydrophilic agent is applied to the surface of the non-woven fabric or the woven fabric, and the raw material of the non-woven fabric or the woven fabric is mixed. Aqueous agent, etc. In the liquid permeable layer, the lipophilic region derived from the hydrocarbon group or the body fluid slip imparting agent and the hydrophilic region derived from the hydrophilic agent are coexisting, and the sliding property is more exhibited because the body fluid is easily moved quickly. To the absorber.

上述膠體乳液並無特別限制,能夠製造。 The above colloidal emulsion is not particularly limited and can be produced.

例如藉由在加熱後的乳液中添加膠體化劑後再混合而製造塗佈液,且藉由將該塗佈液塗佈在應塗佈膠體乳液的吸收性物品之液體透過性層上,能夠製造吸收性物品。 For example, a coating liquid is prepared by adding a colloidizing agent to the heated emulsion, followed by mixing, and by applying the coating liquid to the liquid permeable layer of the absorbent article to which the colloidal emulsion is applied, Manufacture of absorbent articles.

上述膠體乳液能夠依照所期望,作為包含揮發性溶媒,例如包含醇系溶媒、酯系溶媒、芳香族系溶媒等之塗佈液來塗裝。上述塗佈液藉由包含揮發性溶媒,由於上述塗佈液之黏度會下降,能夠達到塗佈容易且不需要塗裝時之加溫等塗佈步驟的簡易化。 The colloidal emulsion can be applied as a coating liquid containing a volatile solvent, for example, an alcohol-based solvent, an ester-based solvent, or an aromatic solvent, as desired. When the coating liquid contains a volatile solvent, the viscosity of the coating liquid is lowered, and the coating step can be easily performed, and the coating step such as heating at the time of coating is not required to be simplified.

上述塗佈液之塗佈方法並無特別限制,能夠因應必要將塗佈液加熱,再以例如非接觸式塗佈機或接觸式塗佈機等進行塗佈。 The coating method of the coating liquid is not particularly limited, and the coating liquid can be heated as necessary, and then applied by, for example, a non-contact coater or a contact coater.

作為上述非接觸式之塗佈機,有舉例如螺旋式塗佈機、淋幕式塗佈機、噴霧式塗佈機、浸漬式塗佈機等,且作為接觸式之塗佈機,有舉例如開槽式塗佈機、圖形式塗佈機等。 As the non-contact type coater, for example, a spiral coater, a curtain coater, a spray coater, a dipping coater, etc., and as a contact coater, there are exemplified examples. Such as slotted coater, graphic coater and the like.

上述塗佈液能夠在製造液體透過性層之素材,例如不織布時被塗佈,或是在製造吸收性物品的生產線中,塗佈於應塗佈膠體乳液之吸收性物品上。以抑制設備投資的觀點來看,在吸收性物品的生產線中,塗佈上述 塗佈液較佳,進而,為了抑制膠體乳液脫落而污染產線,在生產線的下游步驟,具體來說為將製品密封至個別包裝之前,塗佈上述塗佈液較佳。 The coating liquid can be applied to a material for producing a liquid permeable layer, for example, when it is not woven, or can be applied to an absorbent article to which a colloidal emulsion is applied in a production line for producing an absorbent article. In terms of suppressing equipment investment, in the production line of absorbent articles, coating the above The coating liquid is preferred, and further, in order to suppress the colloidal emulsion from falling off and contaminating the production line, it is preferred to apply the coating liquid in the downstream step of the production line, specifically before sealing the product to individual packages.

作為本發明之吸收性物品,有舉例如拋棄式尿布、失禁墊片、生理用衛生棉、護墊。 Examples of the absorbent article of the present invention include disposable diapers, incontinence pads, sanitary napkins, and pads.

本發明也關於一種不織布。 The invention also relates to a nonwoven fabric.

本發明之不織布,與著用者肌膚接觸的區域之至少一部分具有包含膠體化劑與乳液之膠體乳液。 The non-woven fabric of the present invention has a colloidal emulsion containing a colloidizing agent and an emulsion in at least a portion of the area in contact with the user's skin.

上述膠體乳液如以上所述。 The above colloidal emulsion is as described above.

本發明之不織布藉由在與著用者肌膚接觸的區域之至少一部分中具有膠體乳液,能夠連續地釋放出保護著用者肌膚之乳液至著用者的肌膚上。 The non-woven fabric of the present invention has a colloidal emulsion in at least a part of a region in contact with the skin of the user, and can continuously release the emulsion protecting the skin of the user to the skin of the user.

上述膠體乳液在不織布與肌膚接觸的區域之至少一部分中被配置成例如線狀或點狀。 The above colloidal emulsion is disposed, for example, in a line shape or a dot shape in at least a portion of a region where the non-woven fabric is in contact with the skin.

作為包含上述不織布之製品,有舉出口罩、濕紙巾等。 As the product including the above non-woven fabric, there are an outlet cover, a wet tissue, and the like.

[實施例] [Examples]

以下,舉例說明本發明,但本發明並不限定於此等之例。 Hereinafter, the present invention will be described by way of examples, but the present invention is not limited thereto.

[例1] [example 1]

藉由將SEEPS(kuraray股份公司製,Septon4055,苯乙烯含量:30質量%,重量平均分子量:約25萬)(以下 有時省略成「SEEPS-2」)2份添加於加熱至約140℃之PARLEAM EX(日油股份公司製,藉由共聚合流動異烷烴、異丁烯以及n-丁烯後接著加成氫所生成之分支狀烴,且在37.8℃下的動力黏度為10mm2/s)98份中,一邊將此等攪拌5小時,一邊混合,生成混合物,再藉由將該混合物注入直徑40mm之圓筒形容器中至高度為8mm為止,接著冷卻混合物,得到直徑40mm且高度為8mm之圓筒形膠體乳液No.1-1。 By adding SEEPS (Septon 4055, manufactured by Kuraray Co., Ltd., styrene content: 30% by mass, weight average molecular weight: about 250,000) (hereinafter sometimes abbreviated as "SEEPS-2"), 2 parts are added and heated to about 140 ° C. PARLEAM EX (manufactured by Nippon Oil Co., Ltd., a branched hydrocarbon produced by copolymerization of isoparaffin, isobutylene, and n-butene followed by hydrogen addition, and a dynamic viscosity of 10 mm 2 /s at 37.8 ° C) The mixture was stirred for 5 hours while stirring to form a mixture, and the mixture was poured into a cylindrical container having a diameter of 40 mm to a height of 8 mm, and then the mixture was cooled to obtain a diameter of 40 mm and a height of 8 mm. Cylindrical colloidal emulsion No. 1-1.

藉由將SEPS(kuraray股份公司製,Septon2005,苯乙烯含量:20質量%,重量平均分子量:約26萬)(以下有時稱作「SEPS-1」)3份添加於加熱至約140℃之PARLEAM EX92份與矽油(Dow Corning Toray股份公司製,SH200-100cs,二甲基聚矽氧烷,25℃下之動力黏度為100mm2/s)5份之混合物中,一邊將此等攪拌5小時,一邊混合,生成混合物,並藉由將該之後產物注入直徑40mm之圓筒形容器中至高度為8mm為止,接著將混合物冷卻,得到直徑40mm且高度8mm之圓筒形膠體乳液No.1-6。 3 parts of SEPS (septon 2005, septon 2005, styrene content: 20% by mass, weight average molecular weight: about 260,000) (hereinafter sometimes referred to as "SEPS-1") was added to heat to about 140 ° C. PARLEAM EX 92 parts and a mixture of 5 parts of oyster sauce (made by Dow Corning Toray Co., Ltd., SH200-100cs, dimethyl polyoxane, dynamic viscosity at 25 ° C, 100 mm 2 /s), while stirring for 5 hours. While mixing, a mixture was formed, and the product was poured into a cylindrical container having a diameter of 40 mm to a height of 8 mm, and then the mixture was cooled to obtain a cylindrical colloidal emulsion No. 1 having a diameter of 40 mm and a height of 8 mm. 6.

將調配變更成表2所示以外,其餘與膠體乳液No.1-1或膠體乳液No.1-6相同,得到膠體乳液No.1-2~1-5、以及No.1-7~1-20。 The blending was changed to the same as that shown in Table 2, and the same as the colloidal emulsion No. 1-1 or the colloidal emulsion No. 1-6, and the colloidal emulsion No. 1-2 to 1-5, and No. 1-7 to 1 were obtained. -20.

且,表2所記載之化合物的概要雖如以下所述,但關於別處所說明者,省略說明。 Further, the outlines of the compounds described in Table 2 are as follows, but the description of the other places will be omitted.

且,評估膠體乳液No.1-1~1-20之50%變形時的壓縮 應力與靜磨擦係數。統整並表示於表2。 And, the compression at the 50% deformation of the colloidal emulsion No. 1-1 to 1-20 was evaluated. Stress and static friction coefficient. Consolidated and shown in Table 2.

‧SEEPS-1: ‧SEEPS-1:

苯乙烯含量:30質量%,重量平均分子量:約11萬 Styrene content: 30% by mass, weight average molecular weight: about 110,000

‧SEBS-1: ‧SEBS-1:

苯乙烯含量:30質量%,重量平均分子量:約11萬 Styrene content: 30% by mass, weight average molecular weight: about 110,000

‧SEBS-2: ‧SEBS-2:

苯乙烯含量:31質量%,重量平均分子量:約16萬 Styrene content: 31% by mass, weight average molecular weight: about 160,000

‧SEBS-3: ‧SEBS-3:

苯乙烯含量:33質量%,重量平均分子量:約29萬 Styrene content: 33% by mass, weight average molecular weight: about 290,000

‧PARLEAM6: ‧PARLEAM6:

日油股份公司製,藉由共聚合流動異烷烴、異丁烯以及n-丁烯後接著加成氫所生成之分支狀烴,聚合度:約5~約10,重量平均分子量:約330 A branched hydrocarbon produced by co-polymerization of an isoparaffin, isobutylene, and n-butene followed by hydrogen addition, polymerization degree: about 5 to about 10, weight average molecular weight: about 330

[例2] [Example 2]

根據下述表3所記載之調配以外,再根據製造例1之膠體乳液No.1-6的順序,得到直徑40mm且高度8mm之圓筒形膠體乳液No.2-1~2-4。 The cylindrical colloidal emulsion No. 2-1 to 2-4 having a diameter of 40 mm and a height of 8 mm was obtained in the order of the colloidal emulsion No. 1-6 of Production Example 1 in addition to the preparation described in the following Table 3.

且,表3所記載之化合物概要如以下所述。 Further, the compounds described in Table 3 are summarized as follows.

‧NONION OP-80R: ‧NONION OP-80R:

日油股份公司製,單十八烯酸山梨醇酐 Made from Nippon Oil Co., Ltd., oleic acid sorbitan

‧KP-561P ‧KP-561P

信越化學工業股份公司製,丙烯酸酯/丙烯酸硬脂醯/丙烯酸二甲聚矽氧烷共聚合物 Shin-Etsu Chemical Industry Co., Ltd., acrylate/acrylic acid stearin/dimethyl methacrylate copolymer

測定膠體乳液No.2-1~2-4之靜磨擦係數。統整結果並表示於表3。 The static friction coefficient of the colloidal emulsion No. 2-1 to 2-4 was measured. The results are consolidated and shown in Table 3.

[例3] [Example 3]

根據下述表4所記載之調配,且將3g的量注入內徑47mm之玻璃製器皿內以外,根據製造例1之膠體乳液No.1-1或No.1-6的順序,得到膠體乳液No.3-1~3-4。 A colloidal emulsion was obtained according to the order of the colloidal emulsion No. 1-1 or No. 1-6 of Production Example 1, except that the amount of 3 g was poured into a glass vessel having an inner diameter of 47 mm according to the formulation described in the following Table 4. No.3-1~3-4.

根據引證1之實施例4A,準備包含礦油65質量%、與鯨蠟硬脂醇35質量%之乳液組成物,將3g的量注入內徑47mm之玻璃製器皿內,準備膠體乳液No.3-5(比較例)。 According to Example 4A of Citation 1, an emulsion composition containing 65% by mass of mineral oil and 35% by mass of cetearyl alcohol was prepared, and an amount of 3 g was poured into a glass vessel having an inner diameter of 47 mm to prepare a colloidal emulsion No. 3 -5 (comparative example).

將膠體乳液No.3-1~3-5靜置於35℃或20℃之恆溫室中30分鐘,接著,在各膠體乳液上放置已測量質量的3cm×3cm之濾紙,在其上方乘載200g之荷重,1分鐘後將荷重去除,測定濾紙質量之變化。將結果表示於表4。 The colloidal emulsion No. 3-1 to 3-5 was statically placed in a thermostatic chamber at 35 ° C or 20 ° C for 30 minutes, and then a 3 cm × 3 cm filter paper of a measured mass was placed on each of the colloidal emulsions, and loaded thereon. The load of 200 g was taken, and the load was removed after 1 minute, and the change in the quality of the filter paper was measured. The results are shown in Table 4.

由表4可明顯確認到本發明之膠體乳液No.3-1~3-4不會隨溫度變化,會釋放出一定量的乳液,並且指出在寒冷~溫暖的區域中,也能夠同樣地連續釋放出乳液。 It can be clearly confirmed from Table 4 that the colloidal emulsion No. 3-1 to 3-4 of the present invention does not change with temperature, and a certain amount of emulsion is released, and it is pointed out that it can be continuously continuous in a cold to warm region. Release the emulsion.

另一方面,得知膠體乳液No.3-5(比較例)在溫度較低的情形時,較難以釋放出乳液。 On the other hand, it was found that the colloidal emulsion No. 3-5 (comparative example) was more difficult to release the emulsion at a lower temperature.

本發明為關於以下之J1~J10。 The present invention relates to the following J1 to J10.

[J1] [J1]

一種吸收性物品,其特徵為具備液體透過性層、與液體不透過性層、與上述液體透過性層以及液體不透過性層之間的吸收層之吸收性物品,且上述吸收性物品在與著用者肌膚接觸的區域中至少一部分中具有包含膠體化劑與乳液之膠體乳液,上述膠體化劑包含苯乙烯系彈性體,上述乳液包含烴,且上述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 An absorbent article characterized by comprising an absorbent article having a liquid permeable layer, a liquid impermeable layer, and an absorbent layer between the liquid permeable layer and the liquid impermeable layer, wherein the absorbent article is At least a part of the area in contact with the user's skin has a colloidal emulsion containing a colloidizing agent and an emulsion, the colloidizing agent comprising a styrene-based elastomer, the emulsion comprising a hydrocarbon, and the colloidal emulsion having a 50% deformation of 1 to 100 kPa. The compressive stress at the time.

[J2] [J2]

如J1之吸收性物品,其中,上述膠體乳液中,基於此等合計100質量份,分別以1~30質量份以及70~99質量份之比率包含上述膠體化劑以及乳液。 In the above-mentioned colloidal emulsion, the colloidal agent and the emulsion are contained in a ratio of 1 to 30 parts by mass and 70 to 99 parts by mass, respectively, based on 100 parts by mass of the total amount of the above-mentioned colloidal emulsion.

[J3] [J3]

如J1或J2之吸收性物品,其中,上述苯乙烯系彈性體包含兩末端之聚苯乙烯嵌段與其之間的聚烯烴嵌段。 An absorbent article according to J1 or J2, wherein the styrene-based elastomer comprises a polystyrene block at both ends and a polyolefin block therebetween.

[J4] [J4]

如J1~J3中任一項之吸收性物品,其中,上述苯乙烯系彈性體包含10~50質量%的聚苯乙烯嵌段與50~90質量%的聚烯烴嵌段。 The absorbent article according to any one of the above aspects, wherein the styrene-based elastomer comprises 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block.

[J5] [J5]

如J1~J4中任一項之吸收性物品,其中,上述苯乙烯系彈性體具有5,000~500,000之重量平均分子量。 The absorbent article according to any one of J1 to J4, wherein the styrene-based elastomer has a weight average molecular weight of 5,000 to 500,000.

[J6] [J6]

如J1~J5中任一項之吸收性物品,其中,上述膠體乳液進一步包含抗磨劑。 The absorbent article according to any one of J1 to J5, wherein the above colloidal emulsion further comprises an antiwear agent.

[J7] [J7]

如J1~J6中任一項之吸收性物品,其中,上述膠體乳液具有0.01~1.00之靜磨擦係數。 The absorbent article according to any one of J1 to J6, wherein the colloidal emulsion has a static friction coefficient of 0.01 to 1.00.

[J8] [J8]

如J1~J7中任一項之吸收性物品,其中,進一步包含作為上述乳液之體液滑性賦予劑,該體液滑性賦予劑具有超過0.00且為0.60以下之IOB、與在40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 The absorbent article according to any one of the aspects of the present invention, further comprising the body fluid slip imparting agent as the emulsion, wherein the body fluid slip imparting agent has an IOB of more than 0.00 and 0.60 or less, and 0.01 at 40 ° C. A dynamic viscosity of ~80 mm 2 /s, a water holding ratio of 0.01 to 4.0% by mass, and a weight average molecular weight of less than 1,000.

[J9] [J9]

如J1~J8中任一項之吸收性物品,其中,上述膠體乳 液在上述液體透過性層之肌膚接觸區域中被配置成線狀或點狀。 An absorbent article according to any one of J1 to J8, wherein the above colloidal milk The liquid is disposed in a line shape or a dot shape in the skin contact region of the liquid permeable layer.

[J10] [J10]

如J1~J9中任一項之吸收性物品,其係拋棄式尿布、生理用衛生棉或護墊。 An absorbent article according to any one of J1 to J9, which is a disposable diaper, a sanitary napkin or a pad.

[J11] [J11]

一種不織布,其特徵在與著用者肌膚接觸的區域之至少一部分中具有包含膠體化劑與乳液之膠體乳液之不織布,上述膠體化劑包含苯乙烯系彈性體,上述乳液包含烴,且上述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 A non-woven fabric having a non-woven fabric comprising a colloidal emulsion of a colloidizing agent and an emulsion in at least a portion of a region in contact with a user's skin, the colloidizing agent comprising a styrene-based elastomer, the emulsion comprising a hydrocarbon, and the colloid The emulsion has a compressive stress at 50% deformation of 1 to 100 kPa.

1‧‧‧吸收性物品 1‧‧‧Absorbables

2‧‧‧頂部薄片 2‧‧‧Top sheet

3‧‧‧吸收體 3‧‧‧ absorber

4‧‧‧側邊薄片 4‧‧‧Side sheet

5‧‧‧壓印部 5‧‧‧ Imprinting Department

6‧‧‧膠體乳液 6‧‧‧colloidal emulsion

Claims (11)

一種吸收性物品,其特徵為具備液體透過性層、與液體不透過性層、與前述液體透過性層以及液體不透過性層之間的吸收層之吸收性物品,且前述吸收性物品在與著用者肌膚接觸的區域中至少一部分具有包含膠體化劑與乳液之膠體乳液,前述膠體化劑包含苯乙烯系彈性體,前述乳液包含烴,且前述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 An absorbent article characterized by comprising an absorbent article having a liquid permeable layer, a liquid impermeable layer, and an absorbent layer between the liquid permeable layer and the liquid impermeable layer, wherein the absorbent article is At least a part of the area in contact with the user's skin has a colloidal emulsion containing a colloidalizing agent and an emulsion, the colloidalizing agent comprising a styrene-based elastomer, the emulsion comprising a hydrocarbon, and the colloidal emulsion having a 50% deformation of 1 to 100 kPa Compressive stress. 如請求項1之吸收性物品,其中,前述膠體乳液中,基於此等合計100質量份,分別以1~30質量份以及70~99質量份之比率包含前述膠體化劑以及乳液。 The absorbent article according to claim 1, wherein the colloidal emulsion contains the colloidalizing agent and the emulsion in a ratio of 1 to 30 parts by mass and 70 to 99 parts by mass, based on 100 parts by mass in total. 如請求項1或2之吸收性物品,其中,前述苯乙烯系彈性體包含兩末端之聚苯乙烯嵌段與在其之間的聚烯烴嵌段。 The absorbent article of claim 1 or 2, wherein the styrene-based elastomer comprises a polystyrene block at both ends and a polyolefin block therebetween. 如請求項1或2之吸收性物品,其中,前述苯乙烯系彈性體包含10~50質量%的聚苯乙烯嵌段與50~90質量%的聚烯烴嵌段。 The absorbent article according to claim 1 or 2, wherein the styrene-based elastomer comprises 10 to 50% by mass of a polystyrene block and 50 to 90% by mass of a polyolefin block. 如請求項1或2之吸收性物品,其中,前述苯乙烯系彈性體具有5,000~500,000之重量平均分子量。 The absorbent article of claim 1 or 2, wherein the styrene-based elastomer has a weight average molecular weight of 5,000 to 500,000. 如請求項1或2之吸收性物品,其中,前述膠體乳液進一步包含抗磨劑。 The absorbent article of claim 1 or 2, wherein the aforementioned colloidal emulsion further comprises an anti-wear agent. 如請求項1或2之吸收性物品,其中,前述膠體乳液具有0.01~1.00之靜磨擦係數。 The absorbent article of claim 1 or 2, wherein the aforementioned colloidal emulsion has a static friction coefficient of 0.01 to 1.00. 如請求項1或2之吸收性物品,其中,進一步包 含作為前述乳液之體液滑性賦予劑,該體液滑性賦予劑具有超過0.00且0.60以下之IOB、與40℃下為0.01~80mm2/s之動力黏度、與0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量。 The absorbent article according to claim 1 or 2, further comprising a body fluid slip imparting agent as the emulsion, the body fluid slip imparting agent having an IOB of more than 0.00 and 0.60 or less, and 0.01 to 80 mm 2 at 40 ° C / The dynamic viscosity of s, the water holding ratio of 0.01 to 4.0% by mass, and the weight average molecular weight of less than 1,000. 如請求項1或2之吸收性物品,其中,前述膠體乳液在前述液體透過性層之肌膚接觸區域中配置成線狀或點狀。 The absorbent article according to claim 1 or 2, wherein the colloidal emulsion is disposed in a line shape or a dot shape in a skin contact region of the liquid permeable layer. 如請求項1或2之吸收性物品,其係拋棄式尿布、生理用衛生棉或護墊。 The absorbent article of claim 1 or 2, which is a disposable diaper, a sanitary napkin or a pad. 一種不織布,其特徵為在與著用者肌膚接觸的區域之至少一部分中具有包含膠體化劑與乳液之膠體乳液之不織布,前述膠體化劑包含苯乙烯系彈性體,前述乳液包含烴,且前述膠體乳液具有1~100kPa之50%變形時的壓縮應力。 A non-woven fabric characterized by having a non-woven fabric comprising a colloidal emulsion of a colloidizing agent and an emulsion in at least a portion of a region in contact with a user's skin, the colloidizing agent comprising a styrene-based elastomer, the emulsion comprising a hydrocarbon, and the foregoing The colloidal emulsion has a compressive stress at 50% deformation of 1 to 100 kPa.
TW104118147A 2014-06-06 2015-06-04 Absorbent article TWI654968B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-117984 2014-06-06
JP2014117984A JP6416509B2 (en) 2014-06-06 2014-06-06 Absorbent articles

Publications (2)

Publication Number Publication Date
TW201601692A true TW201601692A (en) 2016-01-16
TWI654968B TWI654968B (en) 2019-04-01

Family

ID=54766456

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104118147A TWI654968B (en) 2014-06-06 2015-06-04 Absorbent article

Country Status (3)

Country Link
JP (1) JP6416509B2 (en)
TW (1) TWI654968B (en)
WO (1) WO2015186375A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109312530B (en) * 2016-05-31 2021-08-24 花王株式会社 Non-woven fabric
JP6812703B2 (en) * 2016-08-23 2021-01-13 日油株式会社 Synthetic fiber smoothing agent composition
JP6695397B2 (en) * 2018-10-04 2020-05-20 ユニ・チャーム株式会社 Absorbent article
JP7233356B2 (en) * 2019-11-29 2023-03-06 ユニ・チャーム株式会社 Absorbent article containing lotion composition, and lotion composition
CN113081502A (en) * 2021-05-18 2021-07-09 东莞苏氏卫生用品有限公司 High-efficient ventilative baby diaper of tea tree oil chinese mugwort grass essence skin care
JP2023025797A (en) * 2021-08-11 2023-02-24 ユニ・チャーム株式会社 absorbent article

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2974693B2 (en) * 1988-09-06 1999-11-10 花王株式会社 Surface material for absorbent articles
US6626961B1 (en) * 2000-04-27 2003-09-30 Kimberly-Clark Worldwide, Inc. Nonwovens modified with petrolatum
US7005557B2 (en) * 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
US20060062816A1 (en) * 2001-10-01 2006-03-23 Gatto Joseph A Sanitary napkins with hydrophobic lotions
US7060867B2 (en) * 2002-11-27 2006-06-13 Kimberly-Clark Worldwide, Inc. Absorbent article with a body facing liner having discretely placed lotion deposits
JP6062199B2 (en) * 2012-09-28 2017-01-18 ユニ・チャーム株式会社 Absorbent articles

Also Published As

Publication number Publication date
WO2015186375A1 (en) 2015-12-10
JP6416509B2 (en) 2018-10-31
JP2015229075A (en) 2015-12-21
TWI654968B (en) 2019-04-01

Similar Documents

Publication Publication Date Title
TWI648036B (en) Absorbent article
TWI654968B (en) Absorbent article
TWI580409B (en) Non-woven and absorbent articles
TWI577352B (en) Absorbent items
TWI600413B (en) Absorbent article
JP6116179B2 (en) Absorbent articles
TWI634878B (en) Absorbent article
JP6695397B2 (en) Absorbent article
TWI573576B (en) Absorbent items
TWI594739B (en) Absorbent article
JP7272945B2 (en) Use of absorbent articles, cleaning sheets, and wiping-enhancing compositions
JP7101636B2 (en) Use of absorbent articles, cleaning sheets, and wipe improvers
WO2023017758A1 (en) Absorbent article
JP6618451B2 (en) Absorbent articles, blood modifiers and use of blood modifiers
WO2024029375A1 (en) Absorbent article

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees